EP2134313A2 - Cosmetic composition comprising a fine powder - Google Patents

Cosmetic composition comprising a fine powder

Info

Publication number
EP2134313A2
EP2134313A2 EP08788180A EP08788180A EP2134313A2 EP 2134313 A2 EP2134313 A2 EP 2134313A2 EP 08788180 A EP08788180 A EP 08788180A EP 08788180 A EP08788180 A EP 08788180A EP 2134313 A2 EP2134313 A2 EP 2134313A2
Authority
EP
European Patent Office
Prior art keywords
acid
composition according
copolymers
composition
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08788180A
Other languages
German (de)
French (fr)
Inventor
Karine Loyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arkema France SA
Original Assignee
Arkema France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38752554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2134313(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arkema France SA filed Critical Arkema France SA
Publication of EP2134313A2 publication Critical patent/EP2134313A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88Polyamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up

Definitions

  • the present invention relates to cosmetic compositions used in the field of care and makeup.
  • This composition mainly comprising a continuous aqueous phase, a fat phase and a pulverulent phase of copolyamide powder, which is fine and porous, is in the form of creamy, liquid, gelled compositions. It is in particular an emulsion, but it can also be a biphasic formulation or composition in which the fatty and aqueous phases are separated.
  • the invention relates more particularly to cosmetic compositions for care and / or makeup having a continuous aqueous phase in the case of an oil-in-water emulsion.
  • surfactants thickeners, and more generally surfactants
  • additives such as preservatives and perfumes, but also cosmetic active agents such as moisturizers (polyols), anti-UV agents, anti-wrinkles, self-tanners, film-forming agents and antioxidants. many others.
  • the invention also relates to a process for the makeup and / or care of keratin materials such as the skin, the lips, the nails, the hair, the eyelashes, the eyebrows, the hairs of a human being, including the application of the composition according to the invention on keratin materials.
  • the composition according to the invention may be a make-up and / or skincare composition for keratinous substances, in particular a facial care composition (such as, for example, a moisturizing cream or fluid, anti-wrinkle, and / or or makeup remover ..., but also a two-phase moisturizing and / or make-up removing lotion), a body care composition (such as a moisturizing, slimming composition), a water-resistant sunscreen composition ("waterproof" "In English terminology) or non-water resistant, a makeup composition of the skin, such as a foundation, an eyeshadow, a mascaras, a blusher, a concealer, a product body makeup.
  • a facial care composition such as, for example, a moisturizing cream or fluid, anti-wrinkle, and / or makeup remover ..., but also a two-phase moisturizing and / or make-up removing lotion
  • a body care composition such as a moisturizing, slimming composition
  • a water-resistant sunscreen composition (“
  • compositions of the continuous aqueous phase type have numerous cosmetic and galenical advantages. They are particularly inexpensive and comfortable to use since they do not have a greasy feel. However, their disadvantage is that they have a consistency too close to the consistency of water to be attractive to consumers and present difficulties in the application. In addition, after the disappearance of the feeling of moisture on the skin, they do not improve comfort, care or the visual appearance of the skin (no powdery appearance for example).
  • a cosmetic composition comprising a liquid base, cream or powder, a perfume and a powder formed of spherical, cylindrical or dumbbell-shaped polyamide particles (abbreviated PA). These particles are porous, have an average diameter of 1 to 30 ⁇ m, a specific surface area of 5 m 2 / g or more, an absorption of linseed oil of 200 ml / 100 g or more, a crystallinity of 40% or more and a ratio of the average volume diameter to the number average diameter of 1.0 to 1.5.
  • PA spherical, cylindrical or dumbbell-shaped polyamide particles
  • the homopolyamide powder 12 or 6 of these compositions causes a light-diffusing effect on the surface of the skin and has a high absorption capacity of the sebum, which effectively reduces the abnormal reflection of the light produced on the skin. skin at the time of application of said compositions on the skin.
  • the polyamide powders described in this prior art do not solve the problems encountered for compositions in a continuous aqueous phase: in fact, the homopolyamide powders 6, if they they increase the consistency of the formulations in a continuous aqueous phase, giving the user the feeling of richness that he expects at the time of application, they do not lead, after the application of the formulation, to a soft touch.
  • homopolyamide 12 powders have practically no effect on the consistency of continuous aqueous phase formulations. These retain, despite the addition of polyamide powder, the consistency of water very little appreciated by users. On the other hand, the touch left on the skin after application is very soft.
  • copolyamide powders it was possible to prepare compositions in continuous aqueous phases imparting a feeling of richness to said composition, expected by the users, and leaving, after application, a soft powdery touch.
  • the subject of the invention is a composition which comprises (i) an aqueous phase, (ii) a fatty phase and (iii) a pulverulent phase comprising a copolyamide powder resulting from the polymerization of at least two different monomers described below and optionally other compounds defined below.
  • This composition may be a continuous aqueous phase emulsion (oil in water) or a biphasic composition with a separate aqueous phase and a fatty phase.
  • the continuous aqueous phase according to the invention may comprise thickeners, emollients, humectants (such as polyols) and / or moisturizers.
  • the fatty phase according to the invention may comprise solid or liquid fatty substances of plant, mineral, animal or synthetic origin.
  • esters for example, esters, fatty alcohols, fatty acids, hydrocarbons essentially comprising carbon and hydrogen atoms and possibly nitrogen and oxygen atoms. Mention may also be made of silicone oils and fluorinated oils.
  • the composition is characterized in that the powder particles have a mean diameter ranging from 1 ⁇ m to 200 ⁇ m, preferably from 1 to 100 ⁇ m, even more preferably from 1 to 50 ⁇ m, even more advantageously from 1 ⁇ m to 1 ⁇ m. at 20 ⁇ m, a specific surface area of between 1 and 25 m 2 / g and a spheroidal shape.
  • the composition is characterized in that it comprises (% by weight relative to the total composition):
  • the composition is characterized in that the aqueous phase comprises from 1 to 99% (% by weight relative to the total composition) of polyols, preferably from 10 to 60%.
  • the composition is characterized in that it comprises at least one cosmetic ingredient chosen from antioxidants, perfumes, preservatives, neutralizers, surfactants, film-forming polymers, thickeners, radiation blockers ultra violet, vitamins, dyestuffs, emulsion stabilizers, moisturizers, self-tanning compounds, anti-wrinkle active agents and mixtures thereof.
  • at least one cosmetic ingredient chosen from antioxidants, perfumes, preservatives, neutralizers, surfactants, film-forming polymers, thickeners, radiation blockers ultra violet, vitamins, dyestuffs, emulsion stabilizers, moisturizers, self-tanning compounds, anti-wrinkle active agents and mixtures thereof.
  • the composition is characterized in that it is a moisturizing, anti-wrinkle and / or makeup-removing facial cream or fluid, a cream or a moisturizing and / or slimming body care fluid, a cream water resistant or non-water resistant, foundation, eye shadow, mascara, blush, concealer or body make-up product, two-phase lotion, moisturizing or make-up remover.
  • the invention also relates to the use of a composition for producing a make-up and / or skin care product conferring on the skin giving the skin a soft touch and a matte, powdery appearance after application to said skin. skin.
  • the invention also relates to a cosmetic process for the makeup and / or care of keratin materials, comprising the application to these materials of a composition as described above.
  • the use of the fine and porous powder is characterized in that the powder particles have a mean diameter ranging from 5 to 20 ⁇ m.
  • the use of the fine and porous powder is characterized in that the powder particles have a spheroidal shape.
  • copolyamide powder (abbreviated CoPA powder), it is meant the condensation products of at least two different monomers chosen from:
  • lactams By way of example of lactams, mention may be made of those having from 3 to 12 carbon atoms on the main ring and which may be substituted. Examples that may be mentioned include ⁇ , ⁇ -dimethylpropriolactam, ⁇ , ⁇ -dimethylpropriolactam, amylolactam, caprolactam, capryllactam, oenantholactam, 2-pyrrolidone and lauryllactam.
  • a dicarboxylic acid there may be mentioned acids having between 4 and 18 carbon atoms of carbon. Mention may be made, for example, of adipic acid, sebacic acid, azelaic acid, suberic acid, isophthalic acid, butanedioic acid, 1,4-cyclohexyldicarboxylic acid, terephthalic acid, sodium or lithium salt of sulphoisophthalic acid, dimerized fatty acids (these dimerized fatty acids have a dimer content of at least 98% and are preferably hydrogenated) and dodecanedioic acid HOOC- (CH2) io ⁇ COOH.
  • adipic acid sebacic acid, azelaic acid, suberic acid
  • isophthalic acid butanedioic acid
  • 1,4-cyclohexyldicarboxylic acid 1,4-cyclohexyldicarboxylic acid
  • terephthalic acid sodium or lithium salt of sul
  • a diamine it can be an aliphatic diamine having from 6 to 12 atoms, it can be arylic and / or saturated cyclic.
  • MPDM methyl pentamethylenediamine
  • AMF bis (aminocyclohexyl) methane
  • BMACM bis (3-methyl-4-aminocyclohexyl) methane
  • methaxylyenediamine bis-p-aminocyclohexylmethane and trimethylhexamethylenediamine.
  • the method consists in suspending the lactam in an organic liquid or in a solution in a solvent and in carrying out an anionic polymerization which makes it possible to directly obtain CoPA powder which separates itself from the liquid medium as it is formed.
  • the method of anionic polymerization of lactams is based essentially on the use of a catalyst such as sodium or one of its compounds such as sodium hydride or sodium methoxide and an activator such as lactam-N- carboxyanilides, isocyanates, carbodi-imides, cyanimides, acyl-lactams, triazines, ureas, imides-N-substituted and esters, among others, optionally in the presence of a finely divided mineral or organic filler having a role of crystallization nucleus such as PA powder (for example ORGASOL® powder), silica, talc and in the presence of an N, N'-alkylenebisamide, more particularly N, N'ethylene bis stearamide, N, N'-ethylene bis oleamide, N, N'-ethylene bis palmitamide, gadoleamide, cetoleamide and erucamide, N, N'-dioleyldipamide and N, N'diéruc
  • Copolyamides resulting from the condensation of at least two alpha omega aminocarboxylic acids or two lactams or a lactam and an alpha omega aminocarboxylic acid may be mentioned.
  • alpha-omega amino acids there may be mentioned aminocaproic acid, amino-7-heptanoic acid, amino-11-undecanoic acid and amino-12-dodecanoic acid.
  • copolyamides resulting from the condensation of an aliphatic diamine with an aliphatic dicarboxylic acid and at least one other monomer chosen from aliphatic diamines different from the preceding one and the aliphatic diacids different from the preceding one.
  • copolyamides By way of examples of copolyamides, mention may be made of copolymers of caprolactam and lauryl lactam (PA 6/12), copolymers of caprolactam, adipic acid and hexamethylenediamine (PA 6 / 6-6), copolymers of caprolactam, lauryl lactam, adipic acid and hexamethylenediamine (PA 6/12 / 6-6), copolymers of caprolactam, lauryl lactam, amino undecanoic acid, azelaic acid and hexamethylenediamine (PA 6 / 6-9 / 1 1/12), copolymers of caprolactam, lauryl lactam, 1-undecanoic amino acid, adipic acid and hexamethylenediamine (PA 6 / 6-6) 1/1), copolymers of lauryl lactam, azelaic acid and hexamethylenediamine (PA 6-9 / 12), copoly
  • Polyamide and / or copolyamide can be used. These are, for example, mixtures of aliphatic polyamides and semi-aromatic polyamides and mixtures of aliphatic polyamides and cycloaliphatic polyamides.
  • the powders can be made by any means, dissolved and precipitated in an alcohol.
  • polymerization is produced in a solvent, the powders being insoluble in this solvent (anionic polymerization defined above).
  • anionic polymerization defined above.
  • copolyesteramide powders resulting from the condensation of (the total being 100%):
  • lactams that can be used to make the copolyesteramides are the same as those mentioned above.
  • Caprolactam and lauryllactam are advantageously used.
  • lactones there may be mentioned caprolactone, valerolactone and butyrolactone.
  • Caprolactone is advantageously used.
  • caprolactam, lauryllactam and caprolactone are advantageously used in the following proportions (mol%): 30-46%, 30-46% and 8-40% (the total being 100% ).
  • a fatty phase may contain a liquid fatty phase and possibly a solid fatty phase (such as waxes).
  • the liquid fatty phase may contain one or more liquid oils at room temperature (25 ° C), these oils are volatile or not.
  • the liquid fatty phase is formed of hydrocarbon oils or possibly of silicone oils.
  • the fatty phase comprises one or more oils, that is, immiscible fatty substances with water.
  • oils that is, immiscible fatty substances with water.
  • These volatile or non-volatile oils are of mineral, animal, vegetable or synthetic origin and may be hydrocarbon, silicone or fluorinated.
  • hydrocarbon-based oil means an oil formed essentially or even consisting of carbon and hydrogen atoms and optionally oxygen and nitrogen atoms. It may contain alcohol, ester, ether, carboxylic acid, amine and / or amide groups.
  • nonvolatile liquid oil means an oil capable of remaining on the skin at ambient temperature (25 ° C.) and atmospheric pressure for at least one hour and having in particular a vapor pressure at ambient temperature (25 ° C.) and atmospheric pressure, non-zero, less than or equal to 0.01 mmHg (1.33 Pa).
  • the liquid fatty phase advantageously comprises one or more non-volatile oils which provide an emollient effect on the skin.
  • Fatty esters such as cetearyl isononoate, isostearyl isotridecyl isostearate isononoate, isopropyl isostearate, isopropyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, isononyl isononate, 2-ethylhexyl palmitate, 2-hexyldecyl laurate, 2-octyl decyl palmitate, myristate or 2-octyldodecyl lactate, succinate 2 diethyl hexyl, diisostearyl malate, triisostearate of glycerine or triglycerine, tocopherol acetate, higher fatty acids such as myristic acid, palmitic acid, stearic acid,
  • the composition comprises non-volatile silicone oils such as dimethylsiloxanes.
  • the liquid fatty phase may also optionally comprise volatile oils.
  • volatile oil is meant an oil capable of evaporating from the skin in less than one hour at room temperature and atmospheric pressure. This oil has in particular a vapor pressure at ambient temperature (25 ° C.) and atmospheric pressure (760 mmHg) greater than 0.01 and less than or equal to 300 mmHg (1.33 Pa to 40 000 Pa) and preferably ranging from 0.05 to 300 mmHg (6.65 Pa to 40,000 Pa).
  • the volatile oils are for example chosen from silicone oils which contribute to reducing the fat effect of continuous fat phase formulations. Mention may be made of linear or cyclic silicone oils having a viscosity at room temperature of less than 8 mm 2 / s and in particular having from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups having from 1 to 10 carbon atoms. carbon.
  • volatile silicone oil that may be used in the invention, there may be mentioned in particular actamethyl cyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethylhexyltrisiloxane, heptamethyl octyltrisiloxane, hexamethyl disiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane and mixtures thereof.
  • cyclomethicone DC 345 from Dow Corning
  • caprylyl methicone DC245 from Dow Corning
  • the aqueous phase contains water.
  • the latter may be a floral water such as cornflower water and / or mineral water such as VITTEL water, LUCAS water, LA ROCHE POSAY water and / or thermal water.
  • the aqueous phase may also comprise constituents which are miscible with water, for example primary alcohols such as ethanol and isopropanol, polyols such as glycols added for their humectant properties: glycerol, propylene glycol and butylene. glycol, dipropylene glycol, diethylene glycol, glycol ethers such as mono-, di- or tripropylene glycol (C1-C4) alkyl ethers, mono, di or triethylene glycol and mixtures thereof.
  • primary alcohols such as ethanol and isopropanol
  • polyols such as glycols added for their humectant properties: glycerol, propylene glycol and butylene.
  • the aqueous phase may further comprise stabilizing agents such as sodium chloride, magnesium dichloride and magnesium sulfate.
  • the aqueous phase may also comprise any water-soluble or water-dispersible compounds compatible with an aqueous phase such as gelling agents, film-forming polymers, thickeners, surfactants and their mixture.
  • the cosmetic composition according to the invention may also comprise surfactants (generally lipophilic) of anionic, nonionic or amphoteric type facilitating the dispersion of the fatty phase in the aqueous phase so as to obtain a stable oil / water emulsion, additives such as preservatives (generally hydrophilic), perfumes (generally lipophilic), different fillers of the powder according to the invention, dyestuffs (soluble dyes, pigments), thickeners (waxes, gelling agents), emulsion stabilizers (usually hydrophilic), chelators (usually hydrophilic).
  • surfactants generally lipophilic
  • anionic, nonionic or amphoteric type facilitating the dispersion of the fatty phase in the aqueous phase so as to obtain a stable oil / water emulsion
  • additives such as preservatives (generally hydrophilic), perfumes (generally lipophilic)
  • different fillers of the powder according to the invention dyestuffs (soluble dyes, pigment
  • the surfactants may be of ester type such as sorbitan derivatives (ex sorbitan sesquiisostearate), methyl glucose isostearate. They can be of polymeric types such as PEG-45 / dodecylglycol copolymer. They may also be silicone surfactants suitable for the emulsification of silicone oils: it is for example dimethicone copolyols such as PEG / PPG-18/18 dimethicone marketed by Dow Corning under the name DC5225C.
  • the thickeners may for example be soluble in the fatty phase to adjust its consistency or contribute to the stability of the composition: example candellila wax, gums or silicone elastomers (DC141 1 and DC9040 from Dow Corning).
  • Preservatives are mixtures of derivatives of paraben and / or phenoxyethanol.
  • EDTA ethylene diamine tetraAcetic
  • the cosmetic active agents may also comprise cosmetic active agents that provide an improvement in the human keratin materials mentioned above.
  • the cosmetic active agents include moisturizers (generally hydrophilic) such as polyols, UV radiation blockers such as organic filters (generally lipophilic) or mineral particles such as TiO2, ZnO surface-treated or non-surface treated, anti-wrinkles (generally hydrophilic) , self-tanners (generally hydrophilic), film-forming agents (lipophilic or hydrophilic depending on their nature), antioxidants (lipophilic or hydrophilic depending on their nature).
  • dispersions of ZnO and TiO 2 may be mentioned in silicone oil mixtures.
  • the aqueous phase preferably comprises 1 to 99% by weight of polyols relative to the total aqueous phase, preferably 10 to 60%.
  • it may comprise 0.5 to 10%, preferably 3 to 5% of surfactants, 0.01 to 2% of additives, 0.005 to 10% of cosmetic active ingredients relative to the total composition.
  • the characteristics of the CoPA powders of the composition, object of the invention are:
  • the mean diameter of the particles is from 0.1 to 100 ⁇ m, preferably from 0.5 to 50 ⁇ m, even more advantageously from 1 to 20 ⁇ m.
  • the particle size distribution of the powders is determined according to the usual techniques, for example using a Coulter Multisizer II granulometer according to the ISO 13319 standard. From the particle size distribution, it is possible to determine the mean diameter as well as the particle size dispersion. (standard deviation) which measures the tightening of the distribution. This is one of the advantages of the described method that allow obtain a narrow distribution with a standard deviation of between 1 and 3 ⁇ m, or often less than 2 ⁇ m;
  • the shape of the particles advantageously spheroidal, that is to say in the form of spheroid which means: solid approximately spherical.
  • the characteristics listed above contribute greatly to the soft touch in the continuous aqueous phase systems and to obtaining after application of the matt and powdered appearance of the composition.
  • Powder 1 Orgasol®2002EXD NAT COS, ie PA12 powder, average particle diameter 10 ⁇ m, SSA 4 +/- 1, 5 m 2 / g, flax oil content of 79 g / 100 g, obtained according to the process described in EP192515.
  • Powder 2 ORGASOL® seeded PA12 / PA6 copolyamide powder, 80/20 particle size 10 ⁇ m, SSA 9.5 +/- 1 m 2 / g ,.
  • 2800 ml of solvent are introduced into the reactor maintained under nitrogen, followed successively by 108 g of caprolactam, 679 g of dry lauryl lactam, 14.4 g of EBS and 1 12 g of ORGASOL® 2001 UD NAT1 finely divided. After stirring at 300 rpm, the mixture is gradually heated to 110 ° C. and 290 ml of solvent are then distilled off under vacuum in order to azeotrope traces of water that may be present.
  • the anionic catalyst 7.2 g of sodium hydride at 60% purity in oil, are rapidly introduced under nitrogen and the stirring is increased to 720 r / min under nitrogen at 110 ° C for 30 minutes.
  • the temperature is brought to 96 ° C. and, thanks to a small dosing pump, a continuous injection into the reaction medium of the chosen activator, namely stearyl isocyanate (32.9 g filled to 314 g with solvent), according to the following schedule:
  • the reactor is almost clean.
  • the particle size of between 2 and 20 microns with the average particle diameter being 11, 8 microns and a SSA 9.3 m2 / g without agglomerate.
  • Powder 3 Orgasol®3502 D NAT1 copolyamide powder PA12 / PA6 (50/50), average particle diameter 20 ⁇ m, SSA 2.5 +/- 1 m 2 / g.
  • Powder 4 copolyamide powder PA12 / PA6 (50/50), average particle diameter
  • Powder 5 Orqasol®3202D NAT1 copolyamide powder PA12 / PA6 (20/80), average particle diameter 20 ⁇ m, SSA 1 +/- 1 m 2 / g.
  • Powder 6 Orgasol® 1002 D NAT COS, polyamide 6 powder, average particle diameter 20 ⁇ m, SSA 1 +/- 1 m 2 / g.
  • composition VOOIN does not include powder.
  • compositions comprising the Powders 1 to 6 are defined below for each table.
  • composition is analyzed blind by comparison of all the tests forming a series.
  • compositions A to F and Control 1 are oil-in-water type emulsion compositions comprising 5% fat phase corresponding, for example, to light cream compositions.
  • the process for preparing the compositions below consists in (1) combining and heating at 75 ° C the aqueous phase A, (2) combining and heating at 75 ° C the fat phase B, (3) adding the fat phase B to phase A slowly while stirring vigorously so as to form an emulsion and then (4) cool to room temperature before adding the constituents of phase C with stirring and then the powder (phase D) (except for the control) with gentle stirring .
  • Composition A: x 3.5% of powder 1.
  • Composition B: x 3.5% of powder 2.
  • Composition C: x 3.5% of powder 3.
  • Composition D: x 3.5% of powder 4.
  • Composition E: x 3.5% of powder 5.
  • Composition F: x 3.5% powder 6.
  • compositions G to L and Control 2 of TABLE 2 are compositions of oil-in-water emulsion type comprising 10% fat phase which can correspond for example to moisturizing day creams, so-called rich creams.
  • the method of preparing the compositions below comprises (1) combining and heating at 75 ° C the aqueous phase A, (2) combining and heating at 75 ° C the fat phase B, (3) adding the fat phase B to phase A slowly while stirring vigorously to form an emulsion and then (4) cool to room temperature before adding the constituents of phase C with stirring and then the powder (phase D) (except for the control) with stirring slowly.
  • Composition J: x 3.5% powder 4.
  • COPA powder substantially increases the consistency of the cream and allows it to give an impression of richness to the user, without increasing the compounds oily, which could lead to a greasy feeling
  • CoPA powders containing more than 20 mol% of PA 12 give a softer feel and a more pronounced powdery appearance.
  • compositions M to N and Control 3 of TABLE 3 are compositions comprising oil-in-water emulsion type comprising 15.5% fat phase. These compositions correspond, for example, to anti-wrinkle cream formulations,
  • the smoothing effect of the composition N was measured by the fringe projection method, the principle of which is as follows: the measurement of the cutaneous relief by projection of fringes is carried out at the level of a crow's foot for 20 healthy female subjects.
  • fringe projections makes it possible to objectify changes in the cutaneous topography of the crow's feet.
  • the measurements are made by means of an optical system dedicated to the metrology of the surface relief.
  • This system includes a sensor associated with a projector and a high resolution CCD camera.
  • the average axial and lateral resolutions are of the order of 10 ⁇ m.
  • the analysis of the surface cutaneous topography is performed by calculating the standard parameters of roughness. These parameters are extracted from a surface of 30x40 mm (12 5 cm 2 ), expressed in mm. The quantified parameters are on a series of profiles perpendicular to the lines and wrinkles of the region of interest.
  • the parameter SPt (Maximum amplitude of relief) is extracted.
  • the decrease of SPt signifies an attenuation of the main ride.
  • Formulation N led to a reduction of SPt parameters of 4% after application of the product to the crow's feet area and 6% after 2 hours.
  • compositions O to P and Control 4 of TABLE 4 are oil-in-water emulsion type compositions comprising 26.5% fat phase. These compositions correspond, for example, to sun protection cream formulations with a high degree of protection.
  • the process for preparing the compositions below consists of (1) combining and heating at 70 ° C. the aqueous phase A, (2) combining and heating at 70 ° C. the fatty phase B, (3) adding the fatty phase B to phase A slowly while stirring vigorously to form an emulsifier and then (4) cool to room temperature before adding the constituents of phase C, then (5) phase D with stirring, then (6) the powder (phase E) (except for the control) with gentle shaking.
  • Composition O: x 5% powder 1.
  • Composition P: x 5% powder 2.
  • the copolyamides provide a smoothness and a powdery residue much higher than pure polyamide 12 powders; they decrease more significantly the whitening effect of sunscreens.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to cosmetic compositions used in the care and makeup field. This composition mainly comprising a continuous aqueous phase, a fatty phase and a pulverulent phase of fine and porous copolyamide powder, is in the form of creamy, liquid or gelled compositions. It is in particular an emulsion, but this may also be a two-phase formulation or composition in which the fatty and aqueous phases are separated. The invention more particularly relates to care and/or makeup cosmetic compositions that have a continuous aqueous phase in the case of an oil-in-water emulsion.

Description

COMPOSITION COSMÉTIQUE COMPRENANT UNE POUDRE FINE COSMETIC COMPOSITION COMPRISING A FINE POWDER
La présente invention est relative à des compositions cosmétiques utilisées dans le domaine du soin et du maquillage. Cette composition comprenant principalement une phase aqueuse continue, une phase grasse et une phase pulvérulente de poudre de copolyamide, fine et poreuse, se présente sous forme de compositions crémeuses, liquides, gélifiées. C'est en particulier une émulsion, mais cela peut aussi être une formulation ou composition biphasique dans laquelle les phases grasse et aqueuse sont séparées. L'invention concerne plus particulièrement les compositions cosmétiques pour soin et/ou maquillage présentant une phase aqueuse continue dans le cas d'une émulsion huile dans eau.The present invention relates to cosmetic compositions used in the field of care and makeup. This composition mainly comprising a continuous aqueous phase, a fat phase and a pulverulent phase of copolyamide powder, which is fine and porous, is in the form of creamy, liquid, gelled compositions. It is in particular an emulsion, but it can also be a biphasic formulation or composition in which the fatty and aqueous phases are separated. The invention relates more particularly to cosmetic compositions for care and / or makeup having a continuous aqueous phase in the case of an oil-in-water emulsion.
L'utilisation de tensioactifs, d'épaississants, et plus généralement d'agents de surface, dans les compositions cosmétiques de type émulsion selon l'invention permet d'obtenir une dispersion stable d'une phase dans l'autre. On peut également avoir dans les compositions selon l'invention des additifs tels que des conservateurs et des parfums mais aussi des actifs cosmétiques tels que des hydratants (polyols), des anti- UV, des antirides, des autobronzants, des filmogènes, des antioxydants et bien d'autres.The use of surfactants, thickeners, and more generally surfactants, in the emulsion-type cosmetic compositions according to the invention makes it possible to obtain a stable dispersion from one phase to the other. In the compositions according to the invention, it is also possible to have additives such as preservatives and perfumes, but also cosmetic active agents such as moisturizers (polyols), anti-UV agents, anti-wrinkles, self-tanners, film-forming agents and antioxidants. many others.
L'invention a également pour objet un procédé de maquillage et/ou de soin des matières kératiniques comme la peau, les lèvres, les ongles, les cheveux, les cils, les sourcils, les poils d'être humain, comprenant l'application de la composition selon l'invention sur les matières kératiniques.The invention also relates to a process for the makeup and / or care of keratin materials such as the skin, the lips, the nails, the hair, the eyelashes, the eyebrows, the hairs of a human being, including the application of the composition according to the invention on keratin materials.
La composition selon l'invention peut être une composition de maquillage et/ou de soin des matières kératiniques, en particulier une composition de soin du visage (tel que par exemple une crème ou un fluide à propriété hydratant(e), antirides, et/ou démaquillant(e)...mais aussi une lotion biphasique hydratante et/ou démaquillante), une composition de soin du corps (telle qu'une composition hydratante, amincissante), une composition de crème solaire résistante à l'eau (« waterproof » en terminologie anglo- saxonne) ou non résistante à l'eau, une composition de maquillage de la peau, telle qu'un fond de teint, un fard à paupières, un mascaras, un fard à joue, un produit anticernes, un produit de maquillage du corps.The composition according to the invention may be a make-up and / or skincare composition for keratinous substances, in particular a facial care composition (such as, for example, a moisturizing cream or fluid, anti-wrinkle, and / or or makeup remover ..., but also a two-phase moisturizing and / or make-up removing lotion), a body care composition (such as a moisturizing, slimming composition), a water-resistant sunscreen composition ("waterproof" "In English terminology) or non-water resistant, a makeup composition of the skin, such as a foundation, an eyeshadow, a mascaras, a blusher, a concealer, a product body makeup.
Les compositions de type phase aqueuse continue présentent de nombreux avantages sur le plan cosmétique et galénique. Elles sont notamment peu onéreuses et confortables à l'utilisation puisqu'elles ne présentent pas de toucher gras. Cependant, leur inconvénient est qu'elles ont une consistance trop proche de la consistance de l'eau pour être attractives pour les consommateurs et présentent des difficultés à l'application. De plus, après disparition de la sensation d'humidité sur la peau, elles n'améliorent ni le confort, ni le soin, ni l'aspect visuel de la peau (pas d'aspect poudré par exemple).The compositions of the continuous aqueous phase type have numerous cosmetic and galenical advantages. They are particularly inexpensive and comfortable to use since they do not have a greasy feel. However, their disadvantage is that they have a consistency too close to the consistency of water to be attractive to consumers and present difficulties in the application. In addition, after the disappearance of the feeling of moisture on the skin, they do not improve comfort, care or the visual appearance of the skin (no powdery appearance for example).
Ces problèmes peuvent être résolus en ajoutant des épaississants ou des polyols qui donneront de la consistance aux formulations. Cependant, ce type de produits rend souvent les formulations difficiles à appliquer à cause de l'effet collant, voire poisseux en raison de la présence de polyols. Par ailleurs, ces additifs laissent un effet brillant sur la peau après application et peuvent avoir des effets occlusifs au niveau des pores de la peau.These problems can be solved by adding thickeners or polyols which will give consistency to the formulations. However, this type of product often makes the formulations difficult to apply because of the tacky or sticky effect due to the presence of polyols. In addition, these additives leave a brilliant effect on the skin after application and can have occlusive effects on the pores of the skin.
Dans le document EP 1582194, il est décrit une composition cosmétique comprenant une base liquide, crème ou poudre, un parfum et une poudre formée de particules de polyamide (abrégé PA) sphériques, cylindriques ou en forme d'haltères. Ces particules sont poreuses, ont un diamètre moyen de 1 à 30 μm, une surface spécifique de 5 m2/g ou plus, une absorption d'huile de lin de 200 ml/100g ou plus, une cristallinité de 40% ou plus et un ratio du diamètre moyen en volume par rapport au diamètre moyen en nombre de 1 ,0 à 1 ,5. La poudre d'homopolyamide 12 ou 6 de ces compositions, provoque un effet de diffusion de la lumière à la surface de la peau et a une forte capacité d'absorption du sébum, ce qui diminue efficacement la réflexion anormale de la lumière produite sur la peau au moment de l'application desdites compositions sur la peau.In EP 1582194, there is described a cosmetic composition comprising a liquid base, cream or powder, a perfume and a powder formed of spherical, cylindrical or dumbbell-shaped polyamide particles (abbreviated PA). These particles are porous, have an average diameter of 1 to 30 μm, a specific surface area of 5 m 2 / g or more, an absorption of linseed oil of 200 ml / 100 g or more, a crystallinity of 40% or more and a ratio of the average volume diameter to the number average diameter of 1.0 to 1.5. The homopolyamide powder 12 or 6 of these compositions causes a light-diffusing effect on the surface of the skin and has a high absorption capacity of the sebum, which effectively reduces the abnormal reflection of the light produced on the skin. skin at the time of application of said compositions on the skin.
Par ailleurs, dans ledit document EP1582194, un exemple montre que les poudres d'homopolyamide 6, fabriquées comme décrit dans le texte, confèrent des propriétés sensorielles de type sensation de richesse au moment de l'application supérieures à celles de poudres d'homopolyamide 12, lorsquelles sont introduites dans un fonds de teint.Furthermore, in said document EP1582194, an example shows that the homopolyamide powders 6, manufactured as described in the text, confer sensory properties of the type of feeling of richness at the time of application that are superior to those of homopolyamide powders. , when introduced into a foundation.
Cependant, nous avons constaté, après travaux de recherche, que les poudres de polyamides décrites dans cet art antérieur, ne permettent pas de résoudre les problèmes rencontrés pour les compositions en phase aqueuse continue : en effet, les poudres d'homopolyamide 6, si elles augmentent bien la consistance des formulations en phase aqueuse continue, donnant à l'utilisateur la sensation de richesse qu'il attend au moment de l'application, elles ne conduisent pas, après l'application de la formulation, à un toucher doux. A l'inverse, les poudres d'homopolyamide 12 n'ont pratiquement aucun effet sur la consistance des formulations en phase aqueuse continue. Celles-ci conservent, malgré l'ajout de poudre de polyamide, la consistance de l'eau très peu appréciée par les utilisateurs. En revanche, le toucher laissé sur la peau après application est très doux.However, we have found, after research, that the polyamide powders described in this prior art, do not solve the problems encountered for compositions in a continuous aqueous phase: in fact, the homopolyamide powders 6, if they they increase the consistency of the formulations in a continuous aqueous phase, giving the user the feeling of richness that he expects at the time of application, they do not lead, after the application of the formulation, to a soft touch. Conversely, homopolyamide 12 powders have practically no effect on the consistency of continuous aqueous phase formulations. These retain, despite the addition of polyamide powder, the consistency of water very little appreciated by users. On the other hand, the touch left on the skin after application is very soft.
Nous avons maintenant découvert qu'en utilisant des poudres de copolyamides, il était possible de préparer des compositions en phases aqueuses continue conférant une sensation de richesse à ladite composition, attendue par les utilisateurs, et laissant, après application, un toucher poudré doux.We have now discovered that by using copolyamide powders it was possible to prepare compositions in continuous aqueous phases imparting a feeling of richness to said composition, expected by the users, and leaving, after application, a soft powdery touch.
L'invention a pour objet une composition qui comprend (i) une phase aqueuse, (ii) une phase grasse et (iii) une phase pulvérulente comprenant une poudre de copolyamide issu de la polymérisation d'au moins deux monomères différents décrits plus bas et éventuellement d'autres composés définis ci-dessous. Cette composition peut être une émulsion à phase aqueuse continue (huile dans eau) ou une composition biphasique à phase aqueuse et phase grasse séparées.The subject of the invention is a composition which comprises (i) an aqueous phase, (ii) a fatty phase and (iii) a pulverulent phase comprising a copolyamide powder resulting from the polymerization of at least two different monomers described below and optionally other compounds defined below. This composition may be a continuous aqueous phase emulsion (oil in water) or a biphasic composition with a separate aqueous phase and a fatty phase.
La phase aqueuse continue, selon l'invention, peut comprendre des épaississants, des émollients, des humectants (tels que les polyols) et/ou des hydratants.The continuous aqueous phase according to the invention may comprise thickeners, emollients, humectants (such as polyols) and / or moisturizers.
La phase grasse, selon l'invention, peut comprendre des corps gras solides ou liquides, d'origine végétale, minérale, animale ou de synthèse. On peut citer, par exemple, les esters, les alcools gras, les acides gras, les hydrocarbures comprenant essentiellement des atomes de carbone et d'hydrogène et éventuellement des atomes d'azote, d'oxygène. On peut aussi citer les huiles siliconées et les huiles fluorées.The fatty phase according to the invention may comprise solid or liquid fatty substances of plant, mineral, animal or synthetic origin. There may be mentioned, for example, esters, fatty alcohols, fatty acids, hydrocarbons essentially comprising carbon and hydrogen atoms and possibly nitrogen and oxygen atoms. Mention may also be made of silicone oils and fluorinated oils.
Selon un mode de réalisation, la composition est caractérisée en ce que les particules de poudre ont un diamètre moyen allant de 1 μm à 200 μm, de préférence de 1 à 100μm, encore plus préférentiellement de 1 à 50 μm, encore plus avantageusement de 1 à 20 μm, une surface spécifique comprise entre 1 et 25 m2/g et une forme sphéroïdale.According to one embodiment, the composition is characterized in that the powder particles have a mean diameter ranging from 1 μm to 200 μm, preferably from 1 to 100 μm, even more preferably from 1 to 50 μm, even more advantageously from 1 μm to 1 μm. at 20 μm, a specific surface area of between 1 and 25 m 2 / g and a spheroidal shape.
Selon un mode de réalisation, la composition est caractérisée en ce qu'elle comprend (% en poids par rapport à la composition totale):According to one embodiment, the composition is characterized in that it comprises (% by weight relative to the total composition):
• 59,9 à 98,9%, de préférence 69 à 95% d'une phase aqueuse ; • 0,1 à 30%, de référence 1 à 20% de phase pulvérulente de poudre de CoPA; et59.9 to 98.9%, preferably 69 to 95% of an aqueous phase; 0.1 to 30%, reference 1 to 20% of the powder phase of CoPA powder; and
• 40 à 1 % d'une phase grasse.• 40 to 1% of a fatty phase.
Selon un mode de réalisation, la composition est caractérisée en ce que la phase aqueuse comprend de 1 à 99% (% en poids par rapport à la composition total) de polyols, de préférence 10 à 60%.According to one embodiment, the composition is characterized in that the aqueous phase comprises from 1 to 99% (% by weight relative to the total composition) of polyols, preferably from 10 to 60%.
Selon un mode de réalisation, la composition est caractérisée par le fait qu'elle comprend au moins un ingrédient cosmétique choisi parmi les antioxydants, les parfums, les conservateurs, les neutralisants, les tensioactifs, les polymères filmogènes, les épaississants, les bloqueurs de rayonnements ultra violet, les vitamines, les matières colorantes, les stabilisants d'émulsion, les hydratants, les composés autobronzants, les actifs antirides et leurs mélanges.According to one embodiment, the composition is characterized in that it comprises at least one cosmetic ingredient chosen from antioxidants, perfumes, preservatives, neutralizers, surfactants, film-forming polymers, thickeners, radiation blockers ultra violet, vitamins, dyestuffs, emulsion stabilizers, moisturizers, self-tanning compounds, anti-wrinkle active agents and mixtures thereof.
Selon un mode de réalisation, la composition est caractérisée en ce que c'est une crème ou un fluide de soin du visage hydratant, antirides et/ou démaquillant, une crème ou un fluide de soin du corps hydratant et/ou amincissant, une crème solaire résistante à l'eau ou non résistante à l'eau, un fond de teint, un fard à paupières, un mascara, un fard à joue, un produit anti-cernes ou un produit de maquillage du corps, une lotion biphasique, hydratante ou démaquillante.According to one embodiment, the composition is characterized in that it is a moisturizing, anti-wrinkle and / or makeup-removing facial cream or fluid, a cream or a moisturizing and / or slimming body care fluid, a cream water resistant or non-water resistant, foundation, eye shadow, mascara, blush, concealer or body make-up product, two-phase lotion, moisturizing or make-up remover.
L'invention a également trait à l'utilisation d'une composition pour fabriquer un produit de maquillage et/ou de soin de la peau conférant à la peau conférant à la peau un toucher doux et à un aspect mat et poudré après application sur ladite peau.The invention also relates to the use of a composition for producing a make-up and / or skin care product conferring on the skin giving the skin a soft touch and a matte, powdery appearance after application to said skin. skin.
L'invention concerne aussi un procédé cosmétique de maquillage et/ou de soin des matières kératiniques, comprenant l'application sur ces matières d'une composition telle que décrite précédemment. Selon un mode de réalisation, l'utilisation de la poudre fine et poreuse est caractérisée en ce que les particules de poudre ont un diamètre moyen allant de 5 à 20 μm.The invention also relates to a cosmetic process for the makeup and / or care of keratin materials, comprising the application to these materials of a composition as described above. According to one embodiment, the use of the fine and porous powder is characterized in that the powder particles have a mean diameter ranging from 5 to 20 μm.
Selon un mode de réalisation, l'utilisation de la poudre fine et poreuse est caractérisée en ce que les particules de poudre ont une forme sphéroïdale.According to one embodiment, the use of the fine and porous powder is characterized in that the powder particles have a spheroidal shape.
L'invention va maintenant être décrite plus en détails. POUDREThe invention will now be described in more detail. POWDER
S'agissant de la poudre de copolyamides (abrégé poudre de CoPA), on entend les produits de condensation d'au moins deux monomères différents choisis parmi :As regards the copolyamide powder (abbreviated CoPA powder), it is meant the condensation products of at least two different monomers chosen from:
- les monomères de type aminoacides; - les monomères de type lactames ayant entre 3 à 12 atomes de carbone sur le cycle principal et pouvant être substitués ;amino acid type monomers; - Lactam type monomers having from 3 to 12 carbon atoms on the main ring and may be substituted;
- les monomères issus de la réaction entre une diamine aliphatique ayant entre 6 et 12 atomes de carbone et un diacide carboxylique ayant entre 4 et 18 atomes de carbone; et - leurs mélanges, avec des monomères à nombre de carbone différent dans le cas de mélanges entre un monomère de type aminoacide et un monomère de type lactame.monomers resulting from the reaction between an aliphatic diamine having 6 to 12 carbon atoms and a dicarboxylic acid having from 4 to 18 carbon atoms; and their mixtures with monomers with a different carbon number in the case of mixtures between an amino acid monomer and a lactam monomer.
A titre d'exemple de lactames, on peut citer ceux ayant de 3 à 12 atomes de carbone sur le cycle principal et pouvant être substitués. On peut citer par exemple le β, β-diméthylpropriolactame, le α,α-diméthylpropriolactame, l'amylolactame, le caprolactame, le capryllactame, l'oenantholactame, le 2-pyrrolidone et le lauryllactame.By way of example of lactams, mention may be made of those having from 3 to 12 carbon atoms on the main ring and which may be substituted. Examples that may be mentioned include β, β-dimethylpropriolactam, α, α-dimethylpropriolactam, amylolactam, caprolactam, capryllactam, oenantholactam, 2-pyrrolidone and lauryllactam.
A titre d'exemple d'acide dicarboxylique, on peut citer les acides ayant entre 4 et 18 atomes de carbone de carbone. On peut citer par exemple, l'acide adipique, l'acide sébacique, l'acide azélaique, l'acide subérique, l'acide isophtalique, l'acide butanedioïque, l'acide 1 ,4 cyclohexyldicarboxylique, l'acide téréphtalique, le sel de sodium ou de lithium de l'acide sulphoisophtalique, les acides gras dimérisés(ces acides gras dimérisés ont une teneur en dimère d'au moins 98% et sont de préférence hydrogénés) et l'acide dodécanédioïque HOOC-(CH2)i o~COOH.As an example of a dicarboxylic acid, there may be mentioned acids having between 4 and 18 carbon atoms of carbon. Mention may be made, for example, of adipic acid, sebacic acid, azelaic acid, suberic acid, isophthalic acid, butanedioic acid, 1,4-cyclohexyldicarboxylic acid, terephthalic acid, sodium or lithium salt of sulphoisophthalic acid, dimerized fatty acids (these dimerized fatty acids have a dimer content of at least 98% and are preferably hydrogenated) and dodecanedioic acid HOOC- (CH2) io ~ COOH.
A titre d'exemple de diamine, on peut être une diamine aliphatique ayant de 6 à 12 atomes, elle peut être arylique et/ou cyclique saturée. A titre d'exemples on peut citer l'hexaméthylènediamine, la pipérazine, la tetraméthylène diamine, l'octaméthylène diamine, la décaméthylène diamine, la dodécaméthylène diamine, le 1 ,5 diaminohexane, le 2,2,4-triméthyl-1 ,6-diamino-hexane, les polyols diamine, l'isophorone diamine (IPD), le méthyl pentaméthylènediamine (MPDM), la bis(aminocyclohéxyl) méthane (BACM), la bis(3-méthyl-4 aminocyclohéxyl) méthane (BMACM), la méthaxylyènediamine, le bis-p aminocyclohexylméthane et la triméthylhexaméthylène diamine. Dans le cas d'une synthèse de CoPA à partir de lactames par voie anionique, la méthode consiste à mettre le lactame en suspension dans un liquide organique ou en solution dans un solvant et d'effectuer une polymérisation de type anionique permettant d'obtenir directement de la poudre de CoPA qui se sépare d'elle-même du milieu liquide au fur et à mesure de sa formation. La méthode de polymérisation anionique des lactames est fondée essentiellement sur l'utilisation d'un catalyseur tel que le sodium ou un de ses composés comme l'hydrure de sodium ou le méthylate de sodium et d'un activateur tel que les lactame-N-carboxy-anilides, les isocyanates, les carbodi-imides, les cyanimides, les acyl-lactames, les triazines, les urées, les imides-N-substituées et les esters entre autres en présence éventuellement d'une charge minérale ou organique finement divisée ayant un rôle de germe de cristallisation tel que de la poudre de PA (par exemple de la poudre d'ORGASOL®), de la silice, du talc et en présence d'une N,N'-alkylène bis amide plus particulièrement la N, N'éthylène bis stéaramide, la N.N'éthylène bis oléamide, la N, N'éthylène bis palmitamide, gadoléamide, cétoléamide et érucamide, la N, N'-dioléyldipamide et la N, N'diérucylamide. Le procédé est décrit dans les brevets EP192515 et EP303530.As an example of a diamine, it can be an aliphatic diamine having from 6 to 12 atoms, it can be arylic and / or saturated cyclic. By way of examples, mention may be made of hexamethylenediamine, piperazine, tetramethylene diamine, octamethylene diamine, decamethylene diamine, dodecamethylenediamine, 1,5 diaminohexane and 2,2,4-trimethyl-1,6. Diamino-hexane, diamine polyols, isophorone diamine (IPD), methyl pentamethylenediamine (MPDM), bis (aminocyclohexyl) methane (BACM), bis (3-methyl-4-aminocyclohexyl) methane (BMACM), methaxylyenediamine, bis-p-aminocyclohexylmethane and trimethylhexamethylenediamine. In the case of a synthesis of CoPA from anionic lactams, the method consists in suspending the lactam in an organic liquid or in a solution in a solvent and in carrying out an anionic polymerization which makes it possible to directly obtain CoPA powder which separates itself from the liquid medium as it is formed. The method of anionic polymerization of lactams is based essentially on the use of a catalyst such as sodium or one of its compounds such as sodium hydride or sodium methoxide and an activator such as lactam-N- carboxyanilides, isocyanates, carbodi-imides, cyanimides, acyl-lactams, triazines, ureas, imides-N-substituted and esters, among others, optionally in the presence of a finely divided mineral or organic filler having a role of crystallization nucleus such as PA powder (for example ORGASOL® powder), silica, talc and in the presence of an N, N'-alkylenebisamide, more particularly N, N'ethylene bis stearamide, N, N'-ethylene bis oleamide, N, N'-ethylene bis palmitamide, gadoleamide, cetoleamide and erucamide, N, N'-dioleyldipamide and N, N'diérucylamide. The process is described in patents EP192515 and EP303530.
On peut citer les copolyamides résultant de la condensation d'au moins deux acides alpha oméga aminocarboxyliques ou de deux lactames ou d'un lactame et d'un acide alpha oméga aminocarboxylique. On peut citer comme alpha-oméga aminoacides les acides aminocaproïque, amino-7-heptanoïque, amino-11-undécanoïque et amino- 12-dodécanoïque. On peut encore citer les copolyamides résultant de la condensation d'au moins un acide alpha oméga aminocarboxylique (ou un lactame), au moins une diamine et au moins un acide dicarboxylique. On peut encore citer les copolyamides résultant de la condensation d'une diamine aliphatique avec un diacide carboxylique aliphatique et au moins un autre monomère choisi parmi les diamines aliphatiques différentes de la précédente et les diacides aliphatiques différents du précédent.Copolyamides resulting from the condensation of at least two alpha omega aminocarboxylic acids or two lactams or a lactam and an alpha omega aminocarboxylic acid may be mentioned. As alpha-omega amino acids, there may be mentioned aminocaproic acid, amino-7-heptanoic acid, amino-11-undecanoic acid and amino-12-dodecanoic acid. Mention may also be made of the copolyamides resulting from the condensation of at least one alpha omega aminocarboxylic acid (or a lactam), at least one diamine and at least one dicarboxylic acid. Mention may also be made of the copolyamides resulting from the condensation of an aliphatic diamine with an aliphatic dicarboxylic acid and at least one other monomer chosen from aliphatic diamines different from the preceding one and the aliphatic diacids different from the preceding one.
A titre d'exemples de copolyamides, on peut citer des copolymères de caprolactame et de lauryle lactame (PA 6/12), des copolymères de caprolactame, d'acide adipique et d'hexaméthylène diamine (PA 6/6-6), des copolymères de caprolactame, de lauryle lactame, d'acide adipique et d'hexaméthylène diamine (PA 6/12/6-6), des copolymères de caprolactame, de lauryle lactame, d'acide amino 11 undécanoïque, d'acide azélaïque et d'hexaméthylène diamine (PA 6/6-9/1 1/12), des copolymères de caprolactame, de lauryle lactame, d'acide amino 1 1 undécanoïque, d'acide adipique et d'hexaméthylène diamine (PA 6/6-6/1 1/12), des copolymères de lauryle lactame, d'acide azélaïque et d'hexaméthylène diamine (PA 6-9/12), des copolymères de 2-pyrrolidone et de caprolactame (PA4/6), des copolymères de 2- pyrrolidone et de lauryllactame (PA4/12), des copolymères de caprolactame et d'acide amino 1 1 undécanoïque (PA6/11 ), des copolymères de lauryllactame et de capryllactame (PA12/8), des copolymères de 2-pyrrolidone et d'acide amino 11 undécanoïque (PA11/4), des copolymères de carolactame et de capryllactame (PA8/6), des copolymères de 2-pyrrolidone et de capryllactame (PA8/4), des copolymères de lauryllactame et de capryllactame (PA12/8).By way of examples of copolyamides, mention may be made of copolymers of caprolactam and lauryl lactam (PA 6/12), copolymers of caprolactam, adipic acid and hexamethylenediamine (PA 6 / 6-6), copolymers of caprolactam, lauryl lactam, adipic acid and hexamethylenediamine (PA 6/12 / 6-6), copolymers of caprolactam, lauryl lactam, amino undecanoic acid, azelaic acid and hexamethylenediamine (PA 6 / 6-9 / 1 1/12), copolymers of caprolactam, lauryl lactam, 1-undecanoic amino acid, adipic acid and hexamethylenediamine (PA 6 / 6-6) 1/1), copolymers of lauryl lactam, azelaic acid and hexamethylenediamine (PA 6-9 / 12), copolymers of 2-pyrrolidone and caprolactam (PA4 / 6), copolymers of 2-pyrrolidone and lauryllactam (PA4 / 12), copolymers of caprolactam and 1-undecanoic amino acid (PA6 / 11), copolymers of lauryllactam and capryllactam (PA12 / 8), copolymers of 2-pyrrolidone and amino undecanoic acid (PA11 / 4), copolymers of carolactam and capryllactam (PA8 / 6), copolymers of 2-pyrrolidone and capryllactam (PA8 / 4), copolymers of lauryllactam and capryllactam (PA12 / 8).
On peut utiliser des mélanges de polyamide et/ou de copolyamide. Ce sont par exemple des mélanges de polyamides aliphatiques et de polyamides semi-aromatiques et des mélanges de polyamides aliphatiques et de polyamides cycloaliphatiques.Mixtures of polyamide and / or copolyamide can be used. These are, for example, mixtures of aliphatic polyamides and semi-aromatic polyamides and mixtures of aliphatic polyamides and cycloaliphatic polyamides.
Les poudres peuvent être fabriquées par tout moyen, dissolution et précipitation dans un alcool. Avantageusement, on produit par polymérisation dans un solvant, les poudres étant insolubles dans un ce solvant (polymérisation de type anionique définie plus haut). On peut citer le procédé décrit dans EP192515 et EP303530.The powders can be made by any means, dissolved and precipitated in an alcohol. Advantageously, polymerization is produced in a solvent, the powders being insoluble in this solvent (anionic polymerization defined above). The method described in EP192515 and EP303530 may be mentioned.
On peut aussi utiliser des poudres de copolyesteramides résultant de la condensation de (le total étant 100%) :It is also possible to use copolyesteramide powders resulting from the condensation of (the total being 100%):
• 1 à 98% en moles d'un lactame,1 to 98 mol% of a lactam,
• 1 à 98% en moles d'une lactone, et éventuellement1 to 98 mol% of a lactone, and optionally
• 1 à 98% en moles d'un autre lactame différent du précédent. Les lactames que l'on peut utiliser pour fabriquer les copolyesteramides sont les mêmes que ceux cités plus haut. On utilise avantageusement le caprolactame et le lauryllactame. A titre d'exemple de lactones, on peut citer la caprolactone, la valérolactone et la butyrolactone. On utilise avantageusement la caprolactone.1 to 98 mol% of another lactam different from the previous one. The lactams that can be used to make the copolyesteramides are the same as those mentioned above. Caprolactam and lauryllactam are advantageously used. As examples of lactones, there may be mentioned caprolactone, valerolactone and butyrolactone. Caprolactone is advantageously used.
Dans le cas d'un copolyesteramide, on utilise avantageusement le caprolactame, le lauryllactame et le caprolactone dans les proportions (% molaire) respectives suivantes : 30-46%, 30-46% et 8-40% (le total étant à 100%).In the case of a copolyesteramide, caprolactam, lauryllactam and caprolactone are advantageously used in the following proportions (mol%): 30-46%, 30-46% and 8-40% (the total being 100% ).
Le procédé de préparation de ces poudres de copolyesteramides par polymérisation anionique est décrit dans le document EP1 172396. PHASE GRASSEThe process for the preparation of these copolyesteramide powders by anionic polymerization is described in EP1 172396. FAT PHASE
Une phase grasse peut contenir une phase grasse liquide et éventuellement une phase grasse solide (telles que les cires). La phase grasse liquide peut contenir une ou plusieurs huiles liquides à température ambiante (25°C), ces huiles sont volatiles ou non. La phase grasse liquide est formée d'huiles hydrocarbonées voir éventuellement d'huiles de silicones.A fatty phase may contain a liquid fatty phase and possibly a solid fatty phase (such as waxes). The liquid fatty phase may contain one or more liquid oils at room temperature (25 ° C), these oils are volatile or not. The liquid fatty phase is formed of hydrocarbon oils or possibly of silicone oils.
La phase grasse comprend une ou plusieurs huiles, c'est à dire des corps gras non miscibles à l'eau. Ces huiles volatiles ou non, sont d'origine minérale, animale, végétale ou de synthèse et peuvent être hydrocarbonées, siliconées ou fluorées. Par huile hydrocarbonée, on entend une huile formée essentiellement, voire constituée, d'atomes de carbone et d'hydrogène et éventuellement d'atome d'oxygène, d'azote. Elle peut contenir des groupes alcool, ester, éther, acide carboxylique, aminé et/ou amide.The fatty phase comprises one or more oils, that is, immiscible fatty substances with water. These volatile or non-volatile oils are of mineral, animal, vegetable or synthetic origin and may be hydrocarbon, silicone or fluorinated. The term "hydrocarbon-based oil" means an oil formed essentially or even consisting of carbon and hydrogen atoms and optionally oxygen and nitrogen atoms. It may contain alcohol, ester, ether, carboxylic acid, amine and / or amide groups.
Elle peut contenir une ou plusieurs huiles liquides à température ambiante (25°C), de préférence au moins une huile liquide non volatile. On entend par huile liquide non volatile, une huile susceptible de rester sur la peau à température ambiante (25°C) et pression atmosphérique au moins une heure et ayant notamment une pression de vapeur à température ambiante (25°C) et pression atmosphérique, non nulle, inférieure ou égale à 0,01 mm de Hg (1 ,33 Pa).It may contain one or more liquid oils at ambient temperature (25 ° C.), preferably at least one non-volatile liquid oil. The term "nonvolatile liquid oil" means an oil capable of remaining on the skin at ambient temperature (25 ° C.) and atmospheric pressure for at least one hour and having in particular a vapor pressure at ambient temperature (25 ° C.) and atmospheric pressure, non-zero, less than or equal to 0.01 mmHg (1.33 Pa).
La phase grasse liquide comprend avantageusement une ou plusieurs huiles non volatiles qui procurent un effet émollient sur la peau. On peut citer les esters gras tels que l'isononoate de cetearyl, l'isononoate d'isotridecylj' isostearate d'isostearyl, l'isostearate d'isopropyl, le myristate d'isopropyl, le palmitate d'isopropyl, stéarate de butyle, le laurate d'hexyle, l'isononate d'isononyle, le palmitate de 2-éthyl-hexyle, le laurate de 2-hexyldécyle, le palmitate de 2-octyl décyle, le myristate ou la lactate de 2- octyldodécyle, le succinate de 2-diéthyl hexyle, le malate de diisostéaryle, le tri isostéarate de glycérine ou de triglycérine, l'acétate de tocopherol, les acides gras supérieurs tels que l'acide myristique, l'acide palmitique, l'acide stéarique, l'acide béhénique, l'acide oléique, l'acide linoléique, l'acide linolénique ou l'acide isostéarique, l'acide caprylique/caprique triglycéride, les alcools gras supérieurs tel que l'alcool oléique, l'huile d'avocat, l'huile de camélias, l'huile de noix de macadamia, l'huile de tortue, l'huile de vison, l'huile de soja, l'huile de pépins de raisin, l'huile de sésame, l'huile de mais, l'huile de colza, l'huile de tournesol, l'huile de coton, l'huile de jojoba, l'huile d'arachide, l'huile d'olive, l'hexyl laurate et leurs mélanges. Elles peuvent être des huiles minérales : les huiles d'hydrocarbures telles que l'huile de paraffine, de squalane, la vaseline et leurs mélanges.The liquid fatty phase advantageously comprises one or more non-volatile oils which provide an emollient effect on the skin. Fatty esters such as cetearyl isononoate, isostearyl isotridecyl isostearate isononoate, isopropyl isostearate, isopropyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, isononyl isononate, 2-ethylhexyl palmitate, 2-hexyldecyl laurate, 2-octyl decyl palmitate, myristate or 2-octyldodecyl lactate, succinate 2 diethyl hexyl, diisostearyl malate, triisostearate of glycerine or triglycerine, tocopherol acetate, higher fatty acids such as myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid or isostearic acid, caprylic / capric acid triglyceride, higher fatty alcohols such as oleic alcohol, avocado oil, camellias, macadamia nut oil, turtle oil, mink oil, soybean oil, seed oil grapes, sesame oil, corn oil, rapeseed oil, sunflower oil, cottonseed oil, jojoba oil, peanut oil, oil olive, hexyl laurate and mixtures thereof. They may be mineral oils: hydrocarbon oils such as paraffin oil, squalane, petroleum jelly and mixtures thereof.
Eventuellement, la composition comprend des huiles de silicone non volatiles comme par exemple les diméthyls siloxanes.Optionally, the composition comprises non-volatile silicone oils such as dimethylsiloxanes.
La phase grasse liquide peut aussi comprendre éventuellement des huiles volatiles. Par huile volatile, on entend une huile susceptible de s'évaporer de la peau, en moins d'une heure à température ambiante et pression atmosphérique. Cette huile a notamment une pression de vapeur, à température ambiante (25°C) et pression atmosphérique (760 mm Hg) supérieure à 0,01 et inférieur ou égale à 300 mm de Hg (1 ,33 Pa à 40 000 Pa) et de préférence allant de 0,05 à 300 mm de Hg (6,65 Pa à 40 000 Pa).The liquid fatty phase may also optionally comprise volatile oils. By volatile oil is meant an oil capable of evaporating from the skin in less than one hour at room temperature and atmospheric pressure. This oil has in particular a vapor pressure at ambient temperature (25 ° C.) and atmospheric pressure (760 mmHg) greater than 0.01 and less than or equal to 300 mmHg (1.33 Pa to 40 000 Pa) and preferably ranging from 0.05 to 300 mmHg (6.65 Pa to 40,000 Pa).
Les huiles volatiles sont par exemple choisies parmi les huiles de silicones qui contribuent à réduire l'effet gras des formulations à phase grasse continue. On peut citer les huiles de silicones linéaires ou cycliques ayant une viscosité à température ambiante inférieure à 8 mm2/s et ayant notamment de 2 à 7 atomes de silicium, ces silicones comportant éventuellement des groupes alkyle ou alkoxy ayant de 1 à 10 atomes de carbone. Comme huile de silicone volatile utilisable dans l'invention, on peut citer notamment l'actaméthyl cyclotétrasiloxane, le décaméthyl cyclopentasiloxane, le dodécaméthyl cyclohexasiloxane, l'heptaméthyl hexyl trisiloxane, l'heptaméthyl octyl trisiloxane, l'hexaméthyl disiloxane, l'octaméthyl trisiloxane, le décaméthyl tétrasiloxane, le dodécaméthyl pentasiloxane et leurs mélanges.The volatile oils are for example chosen from silicone oils which contribute to reducing the fat effect of continuous fat phase formulations. Mention may be made of linear or cyclic silicone oils having a viscosity at room temperature of less than 8 mm 2 / s and in particular having from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups having from 1 to 10 carbon atoms. carbon. As volatile silicone oil that may be used in the invention, there may be mentioned in particular actamethyl cyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethylhexyltrisiloxane, heptamethyl octyltrisiloxane, hexamethyl disiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane and mixtures thereof.
Elles sont plus particulièrement de la famille des polyalkyl ou polyaryl siloxanes : le cyclométhicone (DC 345 de Dow Corning), le caprylyl méthicone, le cyclopentasiloxane (DC245 de Dow Corning).They are more particularly from the family of polyalkyl or polyaryl siloxanes: cyclomethicone (DC 345 from Dow Corning), caprylyl methicone, cyclopentasiloxane (DC245 from Dow Corning).
On peut aussi citer les huiles volatiles hydrocarbonées ayant de 8 à 16 atomes de carbone et leurs mélanges et notamment les alcanes ramifiés en C8 à Ci6 comme les isoalcanes (appelés aussi les isoparaffines) en C8 à Ci6, l'isododécane, l'isodécane, l'isohexadécane, les esters ramifiés en C8 à Ci6 comme le néo pentanoate d'isohexyle et leurs mélanges. PHASE AQUEUSECan also be made of volatile hydrocarbon oils having from 8 to 16 carbon atoms and their mixtures and in particular branched alkanes, C 8 to C 6 isoalkanes (also called isoparaffins) C 8 to C 6, isododecane, isodecane, isohexadecane, branched esters, C 8 to C 6 such as isohexyl neopentanoate, and mixtures thereof. AQUEOUS PHASE
La phase aqueuse contient de l'eau. Cette dernière peut être une eau florale telle que l'eau de bleuet et/ou une eau minérale telle que l'eau de VITTEL, l'eau de LUCAS, l'eau de LA ROCHE POSAY et/ou une eau thermale. La phase aqueuse peut également comprendre des constituants miscibles à l'eau comme par exemple les alcools primaires tels que l'éthanol et l'isopropanol, les polyols tels que les glycols ajoutés pour leurs propriétés humectantes: le glycérol, le propylène glycol, le butylène glycol, le dipropylène glycol, le diéthylène glycol, les éthers de glycol tel que les alkyl(C1 -C4)éther de mono, di ou tripropylène glycol, mono, di ou triéthylène glycol et leurs mélanges.The aqueous phase contains water. The latter may be a floral water such as cornflower water and / or mineral water such as VITTEL water, LUCAS water, LA ROCHE POSAY water and / or thermal water. The aqueous phase may also comprise constituents which are miscible with water, for example primary alcohols such as ethanol and isopropanol, polyols such as glycols added for their humectant properties: glycerol, propylene glycol and butylene. glycol, dipropylene glycol, diethylene glycol, glycol ethers such as mono-, di- or tripropylene glycol (C1-C4) alkyl ethers, mono, di or triethylene glycol and mixtures thereof.
La phase aqueuse peut comprendre en outre des agents de stabilisation tels que le chlorure de sodium, le dichlorure de magnésium et le sulfate de magnésium.The aqueous phase may further comprise stabilizing agents such as sodium chloride, magnesium dichloride and magnesium sulfate.
La phase aqueuse peut également comprendre tous composés hydrosolubles ou hydrodispersibles compatibles avec une phase aqueuse tels que les gélifiants, les polymères filmogènes, les épaississants, les tensio-actifs et leur mélange.The aqueous phase may also comprise any water-soluble or water-dispersible compounds compatible with an aqueous phase such as gelling agents, film-forming polymers, thickeners, surfactants and their mixture.
AUTRES COMPOSESOTHER COMPOUNDS
La composition cosmétique selon l'invention peut également comprendre des tensio-actifs ( généralement lipophiles) de type anionique, non ionique ou amphotère facilitant la dispersion de la phase grasse dans la phase aqueuse de façon à obtenir une émulsion huile/eau stable, des additifs tels que des conservateurs (généralement hydrophiles), des parfums (généralement lipophiles), des charges différentes de la poudre selon l'invention, des matières colorantes (colorants solubles, pigments), des épaississants (cires, gélifiants), des stabilisants d'émulsion (généralement hydrophiles), des chélateurs (généralement hydrophiles).The cosmetic composition according to the invention may also comprise surfactants (generally lipophilic) of anionic, nonionic or amphoteric type facilitating the dispersion of the fatty phase in the aqueous phase so as to obtain a stable oil / water emulsion, additives such as preservatives (generally hydrophilic), perfumes (generally lipophilic), different fillers of the powder according to the invention, dyestuffs (soluble dyes, pigments), thickeners (waxes, gelling agents), emulsion stabilizers (usually hydrophilic), chelators (usually hydrophilic).
Les tensio-actifs peuvent être de type ester tels que les dérivés du sorbitan ( ex sorbitan sesquiisostearate), le methyl glucose isostearate. Ils peuvent être de types polymériques tels que le PEG-45/dodécylglycol copolymère. Ils peuvent également être des tensioactifs silicones adaptés à la mise en émulsion des huiles de silicones : il s'agit par exemple de diméthicone copolyols comme le PEG/PPG-18/18 diméthicone commercialisé par Dow Corning sous le nom DC5225C.The surfactants may be of ester type such as sorbitan derivatives (ex sorbitan sesquiisostearate), methyl glucose isostearate. They can be of polymeric types such as PEG-45 / dodecylglycol copolymer. They may also be silicone surfactants suitable for the emulsification of silicone oils: it is for example dimethicone copolyols such as PEG / PPG-18/18 dimethicone marketed by Dow Corning under the name DC5225C.
Les épaississants peuvent être par exemple solubles dans la phase grasse pour ajuster sa consistance ou contribuer à la stabilité de la composition: on peut citer par exemple la cire de candellila, des gommes ou des élastomères de silicones (DC141 1 et DC9040 de Dow Corning).The thickeners may for example be soluble in the fatty phase to adjust its consistency or contribute to the stability of the composition: example candellila wax, gums or silicone elastomers (DC141 1 and DC9040 from Dow Corning).
Les conservateurs sont des mélanges de dérivées des paraben et/ou de phenoxyethanol.Preservatives are mixtures of derivatives of paraben and / or phenoxyethanol.
On peut citer par exemple l'EthylèneDiamineTétraAcétique (EDTA) comme agent chélatant.For example, ethylene diamine tetraAcetic (EDTA) may be mentioned as a chelating agent.
Elle peut aussi comprendre des actifs cosmétiques qui procurent une amélioration des matières kératiniques humaines cités plus haut. Les actifs cosmétiques comprennent les hydratants (généralement hydrophiles) tels que les polyols, les bloqueurs de rayonnements UV tels que les filtres organiques (généralement lipophiles) ou les particules minérales telles que TiO2, ZnO traitées en surface ou non, les antirides (généralement hydrophiles), les autobronzants (généralement hydrophiles), les filmogènes (lipophiles ou hydrophiles selon leur nature), les antioxydants (lipophiles ou hydrophiles selon leur nature).It may also comprise cosmetic active agents that provide an improvement in the human keratin materials mentioned above. The cosmetic active agents include moisturizers (generally hydrophilic) such as polyols, UV radiation blockers such as organic filters (generally lipophilic) or mineral particles such as TiO2, ZnO surface-treated or non-surface treated, anti-wrinkles (generally hydrophilic) , self-tanners (generally hydrophilic), film-forming agents (lipophilic or hydrophilic depending on their nature), antioxidants (lipophilic or hydrophilic depending on their nature).
On peut citer comme filtres minéraux des dispersions de ZnO et de TiO2 dans des mélanges d'huiles de silicones.As mineral filters, dispersions of ZnO and TiO 2 may be mentioned in silicone oil mixtures.
La phase aqueuse comprend pour sa part de préférence 1 à 99% en poids de polyols par rapport à la phase aqueuse totale, de préférence 10 à 60%.The aqueous phase preferably comprises 1 to 99% by weight of polyols relative to the total aqueous phase, preferably 10 to 60%.
De plus, elle peut comprendre 0,5 à 10%, de préférence 3 à 5% de tensioactifs, 0,01 à 2% d'additifs, 0,005 à 10% d'actifs cosmétiques par rapport à la composition totale.In addition, it may comprise 0.5 to 10%, preferably 3 to 5% of surfactants, 0.01 to 2% of additives, 0.005 to 10% of cosmetic active ingredients relative to the total composition.
Les caractéristiques des poudres de CoPA de la composition, objet de l'invention sont :The characteristics of the CoPA powders of the composition, object of the invention are:
• le diamètre moyen des particules est de 0,1 à 100 μm, de préférence de 0,5 à 50 μm, encore plus avantageusement de 1 à 20 μm.The mean diameter of the particles is from 0.1 to 100 μm, preferably from 0.5 to 50 μm, even more advantageously from 1 to 20 μm.
• la répartition granulométrique étroite. La distribution granulométrique des poudres est déterminée selon les techniques habituelles par exemple à l'aide d'un granulomètre Coulter Multisizer II selon la norme ISO 13319. A partir de la distribution granulométrique, il est possible de déterminer le diamètre moyen ainsi que la dispersion granulométrique (écart-type) qui mesure le resserrement de la distribution. C'est l'un des avantages du procédé décrit que de permettre d'obtenir une distribution resserrée avec un écart-type compris entre 1 et 3 μm, voire souvent inférieur à 2 μm ;• narrow particle size distribution. The particle size distribution of the powders is determined according to the usual techniques, for example using a Coulter Multisizer II granulometer according to the ISO 13319 standard. From the particle size distribution, it is possible to determine the mean diameter as well as the particle size dispersion. (standard deviation) which measures the tightening of the distribution. This is one of the advantages of the described method that allow obtain a narrow distribution with a standard deviation of between 1 and 3 μm, or often less than 2 μm;
• la forme des particules de façon avantageuse sphéroïdale, c'est à dire en forme de sphéroïde qui signifie : solide à peu près sphérique.The shape of the particles advantageously spheroidal, that is to say in the form of spheroid which means: solid approximately spherical.
Les caractéristiques énumérées ci-dessus contribuent fortement au toucher doux dans les systèmes de phase aqueuse continue et à l'obtention après application de l'aspect mat et poudré de la composition.The characteristics listed above contribute greatly to the soft touch in the continuous aqueous phase systems and to obtaining after application of the matt and powdered appearance of the composition.
Ces caractéristiques confèrent également aux poudres objets de l'invention la propriété de diminuer l'apparence des rides ou des défauts à la surface de la peau.These characteristics also confer on the powders which are the subject of the invention the property of reducing the appearance of wrinkles or defects on the surface of the skin.
Les exemples des TABLEAUX 1 à 4 ci-dessous sont définis de la façon suivante :The examples in TABLES 1 to 4 below are defined as follows:
Poudre 1 : Orgasol®2002EXD NAT COS c'est à dire poudre de PA12, diamètre moyen des particules 10 μm, SSA 4 +/-1 ,5 m2/g, prise d'huile de lin de 79g/100g, obtenue selon le procédé décrit dans EP192515.Powder 1: Orgasol®2002EXD NAT COS, ie PA12 powder, average particle diameter 10 μm, SSA 4 +/- 1, 5 m 2 / g, flax oil content of 79 g / 100 g, obtained according to the process described in EP192515.
Poudre 2 : poudre de copolyamide PA12/PA6 ensemencé ORGASOL®, 80/20 taille des particules 10 μm, SSA 9,5 +/-1 m2/g,.Powder 2: ORGASOL® seeded PA12 / PA6 copolyamide powder, 80/20 particle size 10 μm, SSA 9.5 +/- 1 m 2 / g ,.
On introduit dans le réacteur maintenu sous azote 2800 ml de solvant, puis successivement 108 g de caprolactame, 679 g de lauryllactame sec, 14,4 g d'EBS, et 1 12 g d'ORGASOL® 2001 UD NAT1 finement divisée. Après avoir mis en route l'agitation à 300 t/min, on chauffe progressivement jusqu'à 110°C, puis on distille sous vide 290 ml de solvant afin d'entraîner par azéotropie des traces d'eau qui pourraient être présentes.2800 ml of solvent are introduced into the reactor maintained under nitrogen, followed successively by 108 g of caprolactam, 679 g of dry lauryl lactam, 14.4 g of EBS and 1 12 g of ORGASOL® 2001 UD NAT1 finely divided. After stirring at 300 rpm, the mixture is gradually heated to 110 ° C. and 290 ml of solvent are then distilled off under vacuum in order to azeotrope traces of water that may be present.
Après retour à la pression atmosphérique, on introduit alors rapidement sous azote le catalyseur anionique, 7,2 g d'hydrure de sodium à 60% de pureté dans de l'huile, et on augmente l'agitation à 720 t/min, sous azote à 1 10°C pendant 30 minutes.After returning to atmospheric pressure, the anionic catalyst, 7.2 g of sodium hydride at 60% purity in oil, are rapidly introduced under nitrogen and the stirring is increased to 720 r / min under nitrogen at 110 ° C for 30 minutes.
Ensuite, on ramène la température à 96°C et grâce à une petite pompe doseuse, on réalise une injection continue dans le milieu réactionnel de l'activateur choisi, à savoir l'isocyanate de stéaryle (32,9 g rempli à 314 g avec du solvant), selon le programme suivant :Then, the temperature is brought to 96 ° C. and, thanks to a small dosing pump, a continuous injection into the reaction medium of the chosen activator, namely stearyl isocyanate (32.9 g filled to 314 g with solvent), according to the following schedule:
> 10 g/h de solution d'isocyanate pendant 300 minutes ;> 10 g / h of isocyanate solution for 300 minutes;
> 88 g/h de solution d'isocyanate pendant 180 minutes ; Parallèlement la température est maintenue à 96°C pendant les 360 premières minutes, puis est montée à 1 10°C en 60 minutes et maintenue à 1 10°C pendant encore> 88 g / h of isocyanate solution for 180 minutes; Meanwhile the temperature is maintained at 96 ° C for the first 360 minutes, then rose to 110 ° C in 60 minutes and maintained at 110 ° C for a further
2 heures après la fin d'introduction de l'isocyanate.2 hours after the end of introduction of the isocyanate.
La polymérisation est alors terminée, le réacteur est presque propre. Après refroidissement à 80°C, décantation et séchage, la granulométrie comprise entre 2 et 20 μm avec le diamètre moyen des particules étant 11 ,8 μm et une SSA 9,3 m2/g sans agglomérat.The polymerization is then complete, the reactor is almost clean. After cooling to 80 ° C, decanting and drying, the particle size of between 2 and 20 microns with the average particle diameter being 11, 8 microns and a SSA 9.3 m2 / g without agglomerate.
Poudre 3 : Orgasol®3502 D NAT1 poudre de copolyamide PA12/PA6 (50/50), diamètre moyen des particules 20 μm, SSA 2,5 +/-1 m2/g. Poudre 4 : poudre de copolyamide PA12/PA6 (50/50), diamètre moyen des particulesPowder 3: Orgasol®3502 D NAT1 copolyamide powder PA12 / PA6 (50/50), average particle diameter 20 μm, SSA 2.5 +/- 1 m 2 / g. Powder 4: copolyamide powder PA12 / PA6 (50/50), average particle diameter
10 μm, SSA 20 +/-1 m2/g, obtenue selon le procédé décrit dans EP192515.10 microns, SSA 20 +/- 1 m 2 / g, obtained according to the process described in EP192515.
Poudre 5 : Orqasol®3202D NAT1 poudre de copolyamide PA12/PA6 (20/80), diamètre moyen des particules 20 μm, SSA 1 +/-1 m2/g.Powder 5: Orqasol®3202D NAT1 copolyamide powder PA12 / PA6 (20/80), average particle diameter 20 μm, SSA 1 +/- 1 m 2 / g.
Poudre 6 : Orgasol®1002 D NAT COS, poudre de polyamide 6, diamètre moyen des particules 20 μm, SSA 1 +/-1 m2/g.Powder 6: Orgasol® 1002 D NAT COS, polyamide 6 powder, average particle diameter 20 μm, SSA 1 +/- 1 m 2 / g.
La composition TEMOIN ne comprend pas de poudre.The composition VOOIN does not include powder.
Les pourcentages ci-dessous sont exprimés en poids par rapport à la composition totale. La nature des compositions comprenant les Poudres 1 à 6 est définie plus bas pour chaque tableau.The percentages below are expressed by weight relative to the total composition. The nature of the compositions comprising the Powders 1 to 6 is defined below for each table.
L'effet de l'addition de poudres PA selon l'invention dans des émulsions à phase aqueuse continue a été mesuré par analyse sensorielle dans différents types de compositions. Chaque composition a fait l'objet d'une étude de profil sensoriel, conduite par un panel de cinq experts selon les descriptifs suivants :The effect of the addition of PA powders according to the invention in continuous aqueous phase emulsions was measured by sensory analysis in different types of compositions. Each composition was the subject of a sensory profile study, conducted by a panel of five experts according to the following descriptions:
pendant la phase d'application du produit : la richesse, la rapidité de pénétration.during the application phase of the product: the wealth, the speed of penetration.
- immédiatement après application : le brillant de la peau, la douceur de la peau, le résidu poudré laissé par la composition sur la peau.- immediately after application: the shine of the skin, the softness of the skin, the powdery residue left by the composition on the skin.
Chaque composition est analysée en aveugle par comparaison de tous les essais formant une série.Each composition is analyzed blind by comparison of all the tests forming a series.
Les résultats sont rassemblés dans les TABLEAUX 1 à 4. Les différents critères ont été évalués sur une échelle allant de 0 à 8. La valeur 0 indiquant l'absence du critère désigné (par exemple une sensation d'absence de douceur) ; la valeur 8 indiquant une tendance très marquée pour le critère choisi (par exemple une sensation très importante de présence de douceur). > Les Compositions A a F et le Témoin 1 sont des compositions de type émulsions Huile dans Eau, comprenant 5% de phase grasse correspondant par exemple à des compositions de crèmes légères.The results are summarized in TABLES 1 to 4. The different criteria were evaluated on a scale from 0 to 8. The value 0 indicates the absence of the designated criterion (for example a sensation of absence of softness); the value 8 indicating a very marked tendency for the chosen criterion (for example a very important sensation of presence of softness). Compositions A to F and Control 1 are oil-in-water type emulsion compositions comprising 5% fat phase corresponding, for example, to light cream compositions.
Le procédé de préparation des compositions ci-dessous consiste à (1 ) combiner et chauffer à 75°C la phase aqueuse A, (2)combiner et chauffer à 75°C la phase grasse B, (3) ajouter la phase grasse B à la phase A lentement tout en agitant énergiquement de façon à former une émulsion puis (4) refroidir à température ambiante avant d'ajouter les constituants de la phase C sous agitation puis la poudre (phase D) (hormis pour le témoin) en agitant doucement.The process for preparing the compositions below consists in (1) combining and heating at 75 ° C the aqueous phase A, (2) combining and heating at 75 ° C the fat phase B, (3) adding the fat phase B to phase A slowly while stirring vigorously so as to form an emulsion and then (4) cool to room temperature before adding the constituents of phase C with stirring and then the powder (phase D) (except for the control) with gentle stirring .
Témoin 1 : x= 0% de poudre. Composition A : x = 3,5% de poudre 1. Composition B : x = 3,5% de poudre 2. Composition C : x = 3,5% de poudre 3. Composition D : x = 3,5% de poudre 4. Composition E : x = 3,5% de poudre 5. Composition F : x = 3,5% de poudre 6.Control 1: x = 0% of powder. Composition A: x = 3.5% of powder 1. Composition B: x = 3.5% of powder 2. Composition C: x = 3.5% of powder 3. Composition D: x = 3.5% of powder 4. Composition E: x = 3.5% of powder 5. Composition F: x = 3.5% powder 6.
TABLEAU 1TABLE 1
> Les Compositions G à L et le Témoin 2 du TABLEAU 2 sont des compositions de type émulsions Huile dans Eau comprenant 10% de phase grasse pouvant correspondre par exemple à des crèmes de jour hydratantes , dites crèmes riches.Compositions G to L and Control 2 of TABLE 2 are compositions of oil-in-water emulsion type comprising 10% fat phase which can correspond for example to moisturizing day creams, so-called rich creams.
Le procédé de préparation des compositions ci-dessous consiste à (1 ) combiner et chauffer à 75"C la phase aqueuse A, (2) combiner et chauffer à 75°C la phase grasse B, (3} ajouter la phase grasse B à la phase A lentement tout en agitant énergiquement de façon à former une émulsion puis (4) refroidir à température ambiante avant d'ajouter les constituants de la phase C sous agitation puis la poudre (phase D) (hormis pour !e témoin) en agitant doucement. The method of preparing the compositions below comprises (1) combining and heating at 75 ° C the aqueous phase A, (2) combining and heating at 75 ° C the fat phase B, (3) adding the fat phase B to phase A slowly while stirring vigorously to form an emulsion and then (4) cool to room temperature before adding the constituents of phase C with stirring and then the powder (phase D) (except for the control) with stirring slowly.
Témoin 2 : x = 0% de poudre.Control 2: x = 0% of powder.
Composition G : x = 3,5% de poudre 1.Composition G: x = 3.5% of powder 1.
Composition H : x = 3,5% de poudre 2. Composition I: x = 3,5% de poudre 3. Composition J: x = 3,5% poudre 4. Composition K: x = 3,5% poudre 5. Composition L: x = 3,5% poudre 6. TABLEAU 2Composition H: x = 3.5% of powder 2. Composition I: x = 3.5% of powder 3. Composition J: x = 3.5% powder 4. Composition K: x = 3.5% powder 5. Composition L: x = 3.5% powder 6. TABLE 2
L'addition de 0.2% à 30% en poids, de préférence de 0.5% à 10%, de poudres de coPA dans une émulsion Huile dans Eau (type crème de jour, fluide hydratant, lait corporel, soin après-rasage entre autre) permet d'apporter de la richesse aux formulations, qui est liée à la consistance. Par ailleurs, après application, l'utilisation de cette poudre de copolyamide permet de conférer à la peau un toucher doux, très supérieur à celui obtenu pour les poudres de PA pures. Enfin, après application, les formulations laissent sur la peau un résidu de poudre qui diffusent la lumière et masque les imperfections. L'addition de poudre permet d'obtenir un aspect mat, lisse, naturel et poudré.The addition of 0.2% to 30% by weight, preferably from 0.5% to 10%, of powders of coPA in an oil-in-water emulsion (type of day cream, moisturizing fluid, body milk, after-shave care, among others) allows to bring richness to the formulations, which is related to the consistency. Furthermore, after application, the use of this copolyamide powder gives the skin a soft feel, much higher than that obtained for pure PA powders. Finally, after application, the formulations leave on the skin a residue of powder which diffuse the light and mask the imperfections. The addition of powder makes it possible to obtain a matt, smooth, natural and powdery appearance.
En particulier, dans une composition du type témoin 1 contenant une faible proportion de phase grasse, l'addition de poudre de COPA augmente sensiblement la consistance de la crème et lui permet de donner une impression de richesse à l'utilisateur, sans augmenter les composés huileux qui pourraient entraîner une sensation de gras Après application, les poudres de CoPA contenant plus de 20% molaire de PA 12 confèrent un toucher plus doux et un rendu poudré plus marqué.In particular, in a composition of the control type 1 containing a small proportion of fatty phase, the addition of COPA powder substantially increases the consistency of the cream and allows it to give an impression of richness to the user, without increasing the compounds oily, which could lead to a greasy feeling After application, CoPA powders containing more than 20 mol% of PA 12 give a softer feel and a more pronounced powdery appearance.
En particulier, dans une composition du type témoin 2 contenant une proportion de phase grasse supérieure, l'addition de poudre coPA augmente sensiblement la consistance de la crème et lui permet de donner une impression de richesse à l'utilisateur, sans augmenter les composés huileux qui pourraient entrainer une sensation de gras. Après application, les poudres de COPA contenant plus de 50% de PA12 confèrent un toucher plus doux, un résidu poudré plus marqué et un effet lissant supérieur. > Les Compositions M à N et le Témoin 3 du TABLEAU 3 sont des compositions comprenant de type émulsions Huile dans Eau comprenant 15,5% de phase grasse. Ces compositions correspondent par exemple aux formulations de crèmes anti-rides ,In particular, in a composition of the control type 2 containing a proportion of higher fatty phase, the addition of coPA powder substantially increases the consistency of the cream and allows it to give an impression of richness to the user, without increasing the oily compounds which could lead to a feeling of fat. After application, COPA powders containing more than 50% PA12 give a softer feel, a more pronounced powdery residue and a superior smoothing effect. Compositions M to N and Control 3 of TABLE 3 are compositions comprising oil-in-water emulsion type comprising 15.5% fat phase. These compositions correspond, for example, to anti-wrinkle cream formulations,
Témoin 3 : x = 0% de poudre.Control 3: x = 0% of powder.
Composition M : x = 3,5% de poudre 1.Composition M: x = 3.5% of powder 1.
Composition N : x = 3,5% de poudre 2. Le procédé de préparation des compositions ci-dessous consiste à (1 ) combiner et chauffer à 75°C la phase aqueuse A, (2) combiner et chauffer à 75°C la phase grasse B, (3} ajouter la phase grasse B à la phase A lentement tout en agitant énergiquement de façon à former une émulsion puis (4) ajouter C juste derrière 5 l'émulsion (pH = 6.9}, puis (5) refroidir à 60°C avant d'ajouter D, puis (6) refroidir à température ambiante avant d'ajouter les constituants de la phase E, puis (7) ajouter la poudre (phase F) (hormis pour le témoin} en agitant doucement.Composition N: x = 3.5% of powder 2. The process for preparing the compositions below consists of (1) combining and heating at 75 ° C. the aqueous phase A, (2) combining and heating at 75 ° C. the fatty phase B, (3) adding the fatty phase B to phase A slowly while stirring vigorously to form an emulsion and then (4) add C just behind the emulsion (pH = 6.9), then (5) cool to 60 ° C before adding D, and then (6) ) cool to room temperature before adding the constituents of phase E, then (7) add the powder (phase F) (except for the control) with gentle shaking.
TABLEAU 3TABLE 3
WW
Dans les formulations de type émulsions Huile dans Eau comprenant 15,5% de phase grasse caractérisées dans le tableau 3, les copolymaides apportent une douceur et un résidu poudré bien supérieurs aux poudres de polyamide 12 purs.In oil-in-water type emulsion formulations comprising 15.5% fat phase characterized in Table 3, the copolymers provide a much smoother and powdered residue than pure polyamide 12 powders.
Par ailleurs, l'effet lissant de la composition N a été mesuré par la méthode de 15 projection de frange, dont le principe est le suivant : la mesure du relief cutané par projection de franges est réalisée au niveau d'une patte d'oie pour 20 sujets sains féminins.Moreover, the smoothing effect of the composition N was measured by the fringe projection method, the principle of which is as follows: the measurement of the cutaneous relief by projection of fringes is carried out at the level of a crow's foot for 20 healthy female subjects.
La technique des projections de franges permet d'objectiver les modifications de la topographie cutanée de la patte d'oie. Les mesures sont réalisées au moyen d'un 0 système optique dédié à la métrologie du relief des surfaces.The technique of fringe projections makes it possible to objectify changes in the cutaneous topography of the crow's feet. The measurements are made by means of an optical system dedicated to the metrology of the surface relief.
Ce système comprend un capteur associé à un projecteur et à une caméra CCD haute résolution. Les résolutions axiale et latérale moyennes sont de l'ordre de 10μm.This system includes a sensor associated with a projector and a high resolution CCD camera. The average axial and lateral resolutions are of the order of 10 μm.
L'analyse de la topographie cutanée de surface est réalisée en calculant les paramètres standards de rugosité. Ces paramètres sont extraits d'une surface de 30x40 mm (12 5 cm2}, exprimés en mm. Les paramètres quantifiés le sont sur une série de profils perpendiculaires aux rides et ridules de la région d'intérêt.The analysis of the surface cutaneous topography is performed by calculating the standard parameters of roughness. These parameters are extracted from a surface of 30x40 mm (12 5 cm 2 ), expressed in mm. The quantified parameters are on a series of profiles perpendicular to the lines and wrinkles of the region of interest.
On extrait par exemple le paramètre SPt (Amplitude maximale du relief). Pour la patte d'oie, la diminution de SPt signifie une atténuation de la ride principale. La formulation N a conduit à une réduction du paramètres SPt de 4% 20minut.es après application du produit sur la zone de la patte d'oie et de 6% après 2 heures.For example, the parameter SPt (Maximum amplitude of relief) is extracted. For the crow's feet, the decrease of SPt signifies an attenuation of the main ride. Formulation N led to a reduction of SPt parameters of 4% after application of the product to the crow's feet area and 6% after 2 hours.
Ce résultat correspond à une diminution significative du paramètre de rugosité SPtThis result corresponds to a significant decrease of the roughness parameter SPt
(amplitude maximale du relief) dès 20 minutes d'application du produit (-4% en moyenne sur l'ensemble du panel), confirmée et amplifiée après 2 heures d'application (-6% en moyenne sur l'ensemble du panel). Cette variation significative traduit une atténuation, en profondeur, de la ride principale de la patte d'oie.(maximum amplitude of the relief) after 20 minutes of application of the product (-4% on average on the entire panel), confirmed and amplified after 2 hours of application (-6% on average over the entire panel) . This significant variation reflects a deep attenuation of the main crease of the crow's feet.
> Les Compositions O à P et le Témoin 4 du TABLEAU 4 sont des compositions de type émulsions Huile dans Eau comprenant 26,5% de phase grasse. Ces compositions correspondent par exemple aux formulations de crèmes solaires à haut indice de protection.Compositions O to P and Control 4 of TABLE 4 are oil-in-water emulsion type compositions comprising 26.5% fat phase. These compositions correspond, for example, to sun protection cream formulations with a high degree of protection.
Pour ce type de formulations, un descriptif supplémentaire a été ajouté dans l'étude sensorielle, spécialement adapté pour les formulations solaires à haut indice de protection : il s'agit du résidu blanc, observé après application, dû aux filtres solaires. Ce descriptif est évalué à 0 lorsqu'après application de la formulation, il ne reste pas de résidu blanc sur la peau ; il est évalué à 8 lorsqu'après application, il reste un résidu blanc important sur la peau.For this type of formulation, an additional description was added in the sensory study, specially adapted for high protection grade solar formulations: this is the white residue, observed after application, due to sunscreens. This description is evaluated at 0 when after application of the formulation, there is no white residue on the skin; it is evaluated at 8 when, after application, a large white residue remains on the skin.
Le procédé de préparation des compositions ci-dessous consiste à (1 ) combiner et chauffer à 700C la phase aqueuse A, (2) combiner et chauffer à 700C la phase grasse B, (3) ajouter la phase grasse B à la phase A lentement tout en agitant énergiquement de façon à former une émulsîon puis (4) refroidir à température ambiante avant d'ajouter les constituants de la phase C, puis (5) de la phase D sous agitation, puis (6) la poudre (phase E) (hormis pour le témoin) en agitant doucement. The process for preparing the compositions below consists of (1) combining and heating at 70 ° C. the aqueous phase A, (2) combining and heating at 70 ° C. the fatty phase B, (3) adding the fatty phase B to phase A slowly while stirring vigorously to form an emulsifier and then (4) cool to room temperature before adding the constituents of phase C, then (5) phase D with stirring, then (6) the powder (phase E) (except for the control) with gentle shaking.
Témoin 4 : x = 0% de poudre. Composition O: x = 5% poudre 1. Composition P : x = 5% poudre 2. TABLEAU 4Control 4: x = 0% powder. Composition O: x = 5% powder 1. Composition P: x = 5% powder 2. TABLE 4
Dans les formulations de type émulsions Huile dans Eau comprenant 26,5% de phase grasse caractérisées dans le tableau 4, les copolyamides apportent une douceur et un résidu poudré bien supérieurs aux poudres de polyamide 12 purs ; elles diminuent de façon plus importante l'effet blanchissant des filtres solaires. In the oil-in-water emulsion type formulations comprising 26.5% fat phase characterized in Table 4, the copolyamides provide a smoothness and a powdery residue much higher than pure polyamide 12 powders; they decrease more significantly the whitening effect of sunscreens.

Claims

REVENDICATIONS
1 . Composition comprenant (i) une phase aqueuse, (ii) une phase grasse et (iii) une phase pulvérulente comprenant une poudre de copolyamide issu de la1. A composition comprising (i) an aqueous phase, (ii) a fatty phase and (iii) a pulverulent phase comprising a copolyamide powder derived from the
5 polymérisation d'au moins deux monomères différents, ladite composition étant soit une émulsion huile dans eau, soit une composition biphasique dont la phase aqueuse et la phase grasse sont séparées.Polymerizing at least two different monomers, said composition being either an oil-in-water emulsion or a two-phase composition in which the aqueous phase and the fat phase are separated.
2. Composition selon la revendication 1 , caractérisée en ce que la poudre deO copolyamides est choisie parmi les produits de condensation d'au moins deux monomères différents choisis parmi :2. Composition according to Claim 1, characterized in that the copolyamide powder is chosen from the condensation products of at least two different monomers chosen from:
- les monomères de type aminoacides;amino acid type monomers;
- les monomères de type lactames ayant entre 3 à 12 atomes de carbone sur le cycle principal et pouvant être substitués ; 5 - les monomères issus de la réaction entre une diamine aliphatique ayant entre 6 et 12 atomes de carbone et un diacide carboxylique ayant entre 4 et 18 atomes de carbone; et- Lactam type monomers having from 3 to 12 carbon atoms on the main ring and may be substituted; Monomers resulting from the reaction between an aliphatic diamine having 6 to 12 carbon atoms and a dicarboxylic acid having from 4 to 18 carbon atoms; and
- leurs mélanges, avec des monomères à nombre de carbone différent dans le cas de mélanges entre un monomère de type aminoacide et un monomère de type lactame. (3. their mixtures with monomers with a different carbon number in the case of mixtures between an amino acid type monomer and a lactam type monomer. (3.
3. Composition selon la revendication 1 ou 2, caractérisée en ce que les lactames sont choisis parmi le β,β-diméthylpropriolactame, le α,α-diméthylpropriolactame, l'amylolactame, le caprolactame, le capryllactame, l'oenantholactame, le 2-pyrrolidone et le lauryllactame. Α. 4. Composition selon la revendication 2, caractérisée en ce que l'acide dicarboxylique est choisi parmi l'acide adipique, l'acide sébacique, l'acide azélaïque, l'acide subérique, l'acide isophtalique, l'acide butanedioïque, l'acide 1 ,3. Composition according to claim 1 or 2, characterized in that the lactams are chosen from β, β-dimethylpropriolactam, α, α-dimethylpropriolactam, amylolactam, caprolactam, capryllactam, oenantholactam, 2- pyrrolidone and lauryllactam. Α. 4. The composition as claimed in claim 2, characterized in that the dicarboxylic acid is chosen from adipic acid, sebacic acid, azelaic acid, suberic acid, isophthalic acid, butanedioic acid, dicarboxylic acid and the like. acid 1,
4 cyclohexyldicarboxylique, l'acide téréphtalique, le sel de sodium ou de lithium de l'acide sulphoisophtalique, les acides gras dimérisés(ces acides gras dimérisés ont une teneur0 en dimère d'au moins 98% et sont de préférence hydrogénés) et l'acide dodécanedioïque HOOC-(CH2)i Q-COOH.Cyclohexyldicarboxylic acid, terephthalic acid, sodium or lithium salt of sulphoisophthalic acid, dimerized fatty acids (these dimerized fatty acids have a dimer content of at least 98% and are preferably hydrogenated) and dodecanedioic acid HOOC- (CH2) i Q-COOH.
5. Composition selon la revendication 2, caractérisée en ce que la diamine est arylique et/ou cyclique saturée. 5. Composition according to claim 2, characterized in that the diamine is aryl and / or cyclic saturated.
6. Composition selon la revendication 2, caractérisée en ce que la diamine est choisi parmi l'hexaméthylènediamine, la pipérazine, la tetraméthylène diamine, l'octaméthylène diamine, la décaméthylène diamine, la dodécaméthylène diamine, le 1 ,5 diaminohexane, le 2,2,4-triméthyl-1 ,6-diamino-hexane, les polyols diamine, l'isophorone diamine (IPD), le méthyl pentaméthylènediamine (MPDM), la bis(aminocyclohéxyl) méthane (BACM), la bis(3-méthyl-4 aminocyclohéxyl) méthane (BMACM), la méthaxylyènediamine, le bis-p aminocyclohexylméthane et la triméthylhexaméthylène diamine.6. Composition according to claim 2, characterized in that the diamine is chosen from hexamethylenediamine, piperazine, tetramethylenediamine, octamethylene diamine, decamethylene diamine, dodecamethylenediamine, 1,5 diaminohexane, 2, 2,4-trimethyl-1,6-diamino-hexane, diamine polyols, isophorone diamine (IPD), methyl pentamethylenediamine (MPDM), bis (aminocyclohexyl) methane (BACM), bis (3-methyl) 4 aminocyclohexyl) methane (BMACM), methaxylyenediamine, bis-p-aminocyclohexylmethane and trimethylhexamethylenediamine.
7 '. Composition selon la revendication 2, caractérisée en ce que les aminoacides sont choisis parmi les alpha oméga aminoacides.7 ' . Composition according to Claim 2, characterized in that the amino acids are chosen from alpha omega amino acids.
8. Composition selon la revendication 7, caractérisée en ce que les alpha-oméga aminoacides sont choisis parmi les acides aminocaproïque, amino-7-heptanoïque, amino-11-undécanoïque et amino-12-dodécanoïque.8. Composition according to Claim 7, characterized in that the alpha-omega amino acids are chosen from aminocaproic acid, amino-7-heptanoic acid, amino-11-undecanoic acid and amino-12-dodecanoic acid.
9. Composition selon l'une des revendications 1 ou 2, caractérisée en ce que les copolyamides sont choisis parmi les copolymères de caprolactame et de lauryle lactame (PA 6/12), les copolymères de caprolactame, d'acide adipique et d'hexaméthylène diamine (PA 6/6-6), les copolymères de caprolactame, de lauryle lactame, d'acide adipique et d'hexaméthylène diamine (PA 6/12/6-6), les copolymères de caprolactame, de lauryle lactame, d'acide amino 11 undécanoïque, d'acide azélaïque et d'hexaméthylène diamine (PA 6/6-9/1 1/12), les copolymères de caprolactame, de lauryle lactame, d'acide amino 1 1 undécanoïque, d'acide adipique et d'hexaméthylène diamine (PA 6/6-6/1 1/12), les copolymères de lauryle lactame, d'acide azélaïque et d'hexaméthylène diamine (PA 6-9/12), les copolymères de 2-pyrrolidone et de caprolactame (PA4/6), les copolymères de 2-pyrrolidone et de lauryllactame (PA4/12), les copolymères de caprolactame et d'acide amino 11 undécanoïque (PA6/11 ), les copolymères de lauryllactame et de capryllactame (PA12/8), les copolymères de 2- pyrrolidone et d'acide amino 11 undécanoïque (PA11/4), les copolymères de carolactame et de capryllactame (PA8/6), les copolymères de 2-pyrrolidone et de capryllactame (PA8/4), les copolymères de lauryllactame et de capryllactame (PA12/8).9. Composition according to one of claims 1 or 2, characterized in that the copolyamides are chosen from copolymers of caprolactam and lauryl lactam (PA 6/12), copolymers of caprolactam, adipic acid and hexamethylene diamine (PA 6 / 6-6), copolymers of caprolactam, lauryl lactam, adipic acid and hexamethylenediamine (PA 6/12 / 6-6), copolymers of caprolactam, lauryl lactam, amino acid undecanoic acid, azelaic acid and hexamethylenediamine (PA 6 / 6-9 / 1 1/12), copolymers of caprolactam, lauryl lactam, amino 1 1 undecanoic acid, adipic acid and hexamethylenediamine (PA 6 / 6-6 / 1 1/12), copolymers of lauryl lactam, azelaic acid and hexamethylenediamine (PA 6-9 / 12), copolymers of 2-pyrrolidone and caprolactam (PA4 / 6), copolymers of 2-pyrrolidone and lauryllactam (PA4 / 12), copolymers of caprolactam and amino-11 undecanoic acid (PA6 / 11), copolymers of lauryl lactam and capryllactam (PA12 / 8), copolymers of 2-pyrrolidone and amino undecanoic acid (PA11 / 4), copolymers of carolactam and capryllactam (PA8 / 6), copolymers of 2- pyrrolidone and capryllactam (PA8 / 4), copolymers of lauryllactam and capryllactam (PA12 / 8).
10. Composition selon l'une des revendications précédentes, caractérisée en ce que les particules de poudres de forme sphéroïdale ont un diamètre moyen allant de 1 μm à 200 μm, de préférence de 1 à 100μm, encore plus préférentiellement de 1 à 50 μm, encore plus avantageusement de 1 à 20 μm10. Composition according to one of the preceding claims, characterized in that the particles of powders of spheroidal shape have a mean diameter ranging from 1 micron to 200 μm, preferably from 1 to 100 μm, even more preferably from 1 to 50 μm, even more advantageously from 1 to 20 μm.
1 1. Composition selon la revendication 12, caractérisée en ce que les particules de 5 poudres ont une surface spécifique comprise entre 1 et 25 m2/g.Composition according to Claim 12, characterized in that the powder particles have a specific surface area of between 1 and 25 m 2 / g.
12. Composition selon l'une des revendications précédentes, caractérisée en ce qu'elle comprend (% en poids par rapport à la composition totale):12. Composition according to one of the preceding claims, characterized in that it comprises (% by weight relative to the total composition):
• 59,9 à 98,9%, de préférence 69 à 95% de phase aqueuse ;59.9 to 98.9%, preferably 69 to 95% aqueous phase;
W • 0,1 à 30%, de préférence 1 à 20% de phase pulvérulente; etW • 0.1 to 30%, preferably 1 to 20% of pulverulent phase; and
• 40 à 1 % d'une phase grasse.• 40 to 1% of a fatty phase.
13. Composition selon l'une des revendications 1 à 3, caractérisée en ce que la poudre est une poudre de copolyesteramide résultant de la condensation de (le total 15 étant 100%) :13. Composition according to one of claims 1 to 3, characterized in that the powder is a copolyesteramide powder resulting from the condensation of (the total being 100%):
• 1 à 98% en moles d'un lactame,1 to 98 mol% of a lactam,
• 1 à 98% en moles d'une lactone, et éventuellement1 to 98 mol% of a lactone, and optionally
• 1 à 98% en moles d'un autre lactame différent du précédent. 01 to 98 mol% of another lactam different from the previous one. 0
14. Composition selon la revendication 13, caractérisée en ce que la lactone est choisie parmi la caprolactone, la valérolactone et la butyrolactone.14. Composition according to claim 13, characterized in that the lactone is chosen from caprolactone, valerolactone and butyrolactone.
15. Composition selon l'une des revendications précédentes, caractérisée en ce que la phase aqueuse comprend de 1 à 99% en poids de polyols par rapport à la phase 5 aqueuse totale, de préférence 10 à 60% en poids.15. Composition according to one of the preceding claims, characterized in that the aqueous phase comprises from 1 to 99% by weight of polyols relative to the total aqueous phase, preferably 10 to 60% by weight.
16. Composition selon l'une des revendications précédentes, caractérisée en ce qu'elle comprend, de plus (% en poids par rapport à la composition totale):16. Composition according to one of the preceding claims, characterized in that it further comprises (% by weight relative to the total composition):
• de 0,5 à 10%, de préférence 3 à 5% de tensioactifs ; 0 • de 0,01 à 2% d'additifs ; etFrom 0.5 to 10%, preferably 3 to 5% of surfactants; 0 • from 0.01 to 2% of additives; and
• de 0,005 à 10% d'actifs cosmétiques. • from 0.005 to 10% of cosmetic assets.
17. Composition selon la revendication 16, caractérisée en ce que les additifs sont choisis parmi les conservateurs, les parfums, les charges différentes de la poudre de copolyamides, les matières colorantes, les épaississants, les stabilisants d'émulsion, les chélateurs.17. Composition according to Claim 16, characterized in that the additives are chosen from preservatives, perfumes, different fillers of the copolyamide powder, dyestuffs, thickeners, emulsion stabilizers and chelators.
5 18. Composition selon la revendication 16 ou 17, caractérisée en ce que les actifs cosmétiques sont choisis parmi les hydratants, les bloqueurs de rayonnements UV, les anti-rides, les autobronzants, les filmogènes, les antioxydants.18. Composition according to claim 16, characterized in that the cosmetic active agents are chosen from moisturizers, UV radiation blockers, anti-wrinkles, self-tanners, film-forming agents and antioxidants.
19. Composition selon l'une des revendications précédentes, caractérisée en ce que c'est une crème ou un fluide de soin du visage hydratant, antirides et/ou démaquillant,19. Composition according to one of the preceding claims, characterized in that it is a cream or a moisturizing facial treatment fluid, anti-wrinkle and / or makeup remover,
W une crème ou un fluide de soin du corps hydratant et/ou amincissant, une crème solaire résistante à l'eau ou non résistante à l'eau, un fond de teint, un fard à paupières, un mascara, un fard à joue, un produit anti-cernes ou un produit de maquillage du corps, une lotion biphasique, hydratante ou démaquillante.W a moisturizing and / or slimming cream or body care fluid, a water-resistant or non-water-resistant sun cream, a foundation, an eyeshadow, a mascara, a blush, a concealer or a body make-up product, a biphasic lotion, moisturizing or cleansing.
20. Utilisation d'une composition selon l'une des revendications précédentes pour 15 fabriquer un produit de maquillage et/ou de soin de la peau conférant à la peau un toucher doux et à un aspect mat et poudré après application sur ladite peau.20. Use of a composition according to one of the preceding claims to make a makeup product and / or skin care giving the skin a soft touch and a matte and powdery appearance after application to said skin.
21. Procédé cosmétique de maquillage et/ou de soin des matières kératiniques, comprenant l'application sur ces matières d'une composition selon l'une des revendications 1 à 19. 021. A cosmetic process for making up and / or caring for keratin materials, comprising the application to these materials of a composition according to one of claims 1 to 19. 0
55
0 0
EP08788180A 2007-04-12 2008-04-14 Cosmetic composition comprising a fine powder Withdrawn EP2134313A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0754431A FR2914856B1 (en) 2007-04-12 2007-04-12 COSMETIC COMPOSITION COMPRISING A FINE POWDER
PCT/FR2008/050662 WO2008145889A2 (en) 2007-04-12 2008-04-14 Cosmetic composition comprising a fine powder

Publications (1)

Publication Number Publication Date
EP2134313A2 true EP2134313A2 (en) 2009-12-23

Family

ID=38752554

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08788180A Withdrawn EP2134313A2 (en) 2007-04-12 2008-04-14 Cosmetic composition comprising a fine powder

Country Status (11)

Country Link
US (1) US10463889B2 (en)
EP (1) EP2134313A2 (en)
JP (1) JP5551580B2 (en)
KR (1) KR101516444B1 (en)
CN (1) CN101677915B (en)
AU (1) AU2008257296A1 (en)
BR (1) BRPI0810537B1 (en)
FR (1) FR2914856B1 (en)
MX (1) MX336952B (en)
RU (1) RU2009141710A (en)
WO (1) WO2008145889A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008051007A1 (en) * 2008-10-13 2010-04-15 Beiersdorf Ag Polyamide-5 compounds in cosmetic preparations
FR2962042B1 (en) 2010-07-01 2013-02-08 Arkema France COSMETIC COMPOSITION COMPRISING COPA.
NZ615623A (en) 2011-03-02 2015-06-26 Pibed Ltd Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
FR2979235B1 (en) * 2011-08-26 2015-04-03 Lvmh Rech MASCARA IN THE FORM OF POWDER
KR101584410B1 (en) * 2013-12-04 2016-01-13 지에스칼텍스 주식회사 Nylon blend composition having improved heat resistance and impact strength and method for preparing the same
FR3019040B1 (en) * 2014-03-31 2016-03-11 Arkema France COSMETIC COMPOSITION FOR SKIN LIGHTENING
WO2017217660A1 (en) * 2016-06-13 2017-12-21 연세대학교 산학협력단 Composition containing suberic acid or salt thereof as active ingredient, and having effects of improving skin moisturization, skin exfoliation, enhancing skin elasticity, inhibiting erythema, alleviating skin wrinkles, or alleviating skin photoaging
KR102360818B1 (en) * 2017-06-30 2022-02-09 (주)아모레퍼시픽 Water Dispersion Liquid Cosmetic Composition for Eye-makeup
KR20190037454A (en) * 2017-09-29 2019-04-08 (주)아모레퍼시픽 Priming cosmetic composition and manufacturing method of the same
CN110974715B (en) * 2019-12-26 2023-08-01 常州纳欧新材料科技有限公司 APG modified MBBT composite material and preparation method of aqueous slurry thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661546A1 (en) * 2004-11-30 2006-05-31 Arkema Cosmetic composition comprising a fine and porous powder

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478465A1 (en) * 1980-03-18 1981-09-25 Oreal NEW COSMETIC COMPOSITIONS FOR HAIR, IN TWO LIQUID PHASES, AND THEIR APPLICATION
US4610919A (en) * 1985-06-14 1986-09-09 Fiber Bond Corporation Binder for fibrous padding
US5874091A (en) * 1990-09-27 1999-02-23 L'oreal Cosmetic composition comprising a dispersion of lipid vesicles as well as melanin pigments
JP4089852B2 (en) * 1999-03-01 2008-05-28 住化エンビロサイエンス株式会社 Production method of coarse copolymer polyamide fine particles
FR2811669A1 (en) 2000-07-11 2002-01-18 Atofina PROCESS FOR THE PREPARATION OF POROUS POWDERS OF COPOLYESTERAMIDES AND POWDERS THUS OBTAINED
JP2007500749A (en) * 2003-06-09 2007-01-18 カラー アクセス,インコーポレイティド Stable cosmetic emulsion containing polyamide
EP1676556B1 (en) * 2004-10-22 2012-01-11 L'Oréal Cosmetic composition containing a polyorganosiloxane polymer
DE102004058073A1 (en) 2004-12-01 2006-06-08 Basf Ag Process for the preparation of an aqueous polyamide dispersion
WO2006126563A1 (en) * 2005-05-25 2006-11-30 Toray Industries, Inc. Polyamide resin fine particles and process for production thereof
JP4951893B2 (en) * 2005-08-23 2012-06-13 東レ株式会社 Polycaproamide resin fine particles and cosmetics containing the same
FR2903595B1 (en) * 2006-07-11 2008-08-22 Rhodia Recherches & Tech COSMETIC COMPOSITIONS COMPRISING A THERMOPLASTIC MATERIAL POWDER

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661546A1 (en) * 2004-11-30 2006-05-31 Arkema Cosmetic composition comprising a fine and porous powder

Also Published As

Publication number Publication date
CN101677915A (en) 2010-03-24
WO2008145889A3 (en) 2009-02-19
BRPI0810537B1 (en) 2021-03-02
KR101516444B1 (en) 2015-05-07
WO2008145889A2 (en) 2008-12-04
BRPI0810537A2 (en) 2020-08-18
JP2010523631A (en) 2010-07-15
CN101677915B (en) 2015-05-20
US20100215701A1 (en) 2010-08-26
MX2009011000A (en) 2009-12-11
RU2009141710A (en) 2011-05-20
US10463889B2 (en) 2019-11-05
FR2914856A1 (en) 2008-10-17
FR2914856B1 (en) 2012-08-03
KR20100016340A (en) 2010-02-12
JP5551580B2 (en) 2014-07-16
MX336952B (en) 2016-02-03
AU2008257296A1 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
EP2134313A2 (en) Cosmetic composition comprising a fine powder
CA2526279C (en) Cosmetic composition comprising a fine, porous powder
EP0908175B1 (en) Stable topical composition containing a solid elastomeric organopolysiloxane and spherical particles
EP1870076A2 (en) Solid emulsion with liquid oil phase structured by a polymer
EP2421494B1 (en) Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of at least one cosmetic or pharmaceutical agent
FR3073411A1 (en) COMPOSITION COMPRISING A FATTY PHASE, A LIPOPHILIC POLYMER AND A VOLATILE HYDROCARBON OIL
FR2757396A1 (en) CARE COMPOSITION CONTAINING ORGANOPOLYSILOXANE GEL
FR2908982A1 (en) Cosmetic composition for making up and caring for skin, lips and keratin fibres, comprises one or more aprotic hydrocarbon-based volatile solvent comprising not more than one branch, in physiologically acceptable medium
EP1925292A1 (en) Cosmetic composition comprising at least one volatile carbonic acid ester
EP1925291B1 (en) Cosmetic composition comprising at least one volatile ester
WO2009092934A1 (en) Cosmetic composition, in particular makeup composition for keratinic materials, having improved cosmetic properties
FR2892019A1 (en) Caring for wrinkled skin comprises applying composition including pulverulent phase comprising porous particles which comprise antiwrinkle active principle; and applying composition including fatty and/or aqueous phase comprising solvent
EP1516610B1 (en) Cosmetic composition containing colloidal particles as inorganic filler
FR2964562A1 (en) Cosmetic product, useful in cosmetic process for caring keratin materials, comprises a composition comprising aqueous phase and fatty phase, and composition comprising a mixture of organopolysiloxane elastomer and silicone oil
FR3006177A1 (en) COSMETIC USE AS A DEODORANT ACTIVE OF A SILICY MATERIAL OBTAINED BY HYDROLYSIS AND CONDENSATION OF A TETRAALCOXYSILANE AND AN AMINOALKYL TRIALCOXYSILANE
AU2012202501B2 (en) Cosmetic composition comprising a fine powder
FR2952528A1 (en) MIXTURE OF SOLVENTS HYDROCARBONES.
FR2898049A1 (en) Cosmetic process, useful for lip care or make-up e.g. to moisturize the lips, comprises topical application of a composition containing an oil emulsion of cyclic lipopeptide e.g. surfactin in a polar phase e.g. water-polyol mixture
FR2954106A1 (en) COLORED COMPOSITION FOR CAMOUFLING SKIN IMPERFECTIONS
WO2020128392A1 (en) Anhydrous cosmetic composition comprising a polysilsesquioxane film-forming resin
FR2954105A1 (en) Cosmetic composition in the form of oil-in-water emulsion, useful e.g. as foundation, comprises volatile linear alkane and powder colorant material treated in surface with lipophilic or hydrophobic treatment agent, in a medium
FR2915894A1 (en) Composition in oil-in-water emulsion form, useful for make-up and/or care of keratinous material, comprises an internal fatty phase and external aqueous phase comprising an inulin modified by hydrophobic chain
FR3042707A1 (en) AQUEOUS COMPOSITION COMPRISING AN ORGANOSILANE OR OLIGOMER OF THE SAME ORGANOSILANE AND A HYDROPHOBIC COATED PIGMENT
FR2997843A1 (en) Cosmetic composition of water-in-silicone emulsion type, useful as make-up product for caring keratinous material i.e. dark skin, comprises oily phase and ferric blue pigment surface treated with hydrophobic or lipophilic curing agent
FR2873580A1 (en) Cosmetic composition, useful for e.g. make-up or non-therapeutic treatment of keratinous fibers, comprises cyclic volatile silicon oil and linear volatile alkyltrisiloxane oil in a medium

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091008

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20120810

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APBV Interlocutory revision of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNIRAPE

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 19/00 20060101ALI20190327BHEP

Ipc: A61K 8/88 20060101AFI20190327BHEP

INTG Intention to grant announced

Effective date: 20190425

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

INTC Intention to grant announced (deleted)
APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20231101